US3850161A - Method and apparatus for monitoring and counteracting excess brain electrical energy to prevent epileptic seizures and the like - Google Patents

Method and apparatus for monitoring and counteracting excess brain electrical energy to prevent epileptic seizures and the like Download PDF

Info

Publication number
US3850161A
US3850161A US00348864A US34886473A US3850161A US 3850161 A US3850161 A US 3850161A US 00348864 A US00348864 A US 00348864A US 34886473 A US34886473 A US 34886473A US 3850161 A US3850161 A US 3850161A
Authority
US
United States
Prior art keywords
brain
signal
circuit
electrode
monitoring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00348864A
Inventor
S Liss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US00348864A priority Critical patent/US3850161A/en
Application granted granted Critical
Publication of US3850161A publication Critical patent/US3850161A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/369Electroencephalography [EEG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/40Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4094Diagnosing or monitoring seizure diseases, e.g. epilepsy

Definitions

  • ABSTRACT This invention pertains to a biomedical detecting and control apparatus wherein electrical signals in the brain of mammals are continuously monitored by electrodes implanted in certain critical places in the brain wherein excess electrical energy is manifest during epileptic seizure conditions as well as during psychic storms of some types of mental illness. Such signals are processed via electrical systems of various circuits for inversion, comparison, vector analog addition, filtering, modulation, level set, safety level limits and self test to provide a controlled signal output which automatically reduces or eliminates the excess electrical energy at the point of detection.
  • the points of detection and control may be, but do not have to be, the same spots on the brain.
  • the probes may be near the surface of the brain or deep set in the brain depending upon the area affected.
  • an electronic device which is contemplated to be housed in a small housing outside the body of the mammal and connected through wire conductors connected to the electrodes at the point of detection and at the other end of the conductors to outlet connectors in the housing providing the point of control.
  • Temporal lobe epilepsy is a typical disease where it is believed to be necessary to provide deep implanted electrodes; first of all to detect the electrical presence of the aberrant energy and second of all to counteract locally this excessive aberrant energy.
  • the method and apparatus of this invention is intended to provide the detection means and the electrical signals necessary to counteract and restrain these excesses.
  • This invention may be summarized at least in part with reference to its objects. It is an object of this invention to provide both the method and the means of monitoring the brain of a mammal by means of permanently inserted electrodes in selected critical areas of the brain. By connecting these electrodes to a monitoring device, safety limits for brain signal outputs can be evaluated and upon indications of excess outputs counteracting signals can be fed to the brain to prevent aberrant activity as produced in certain mental illness conditions and epilepsy seizures.
  • FIG. 3 represents a diagram showing the attachment of and the support of the apparatus to and by a human.
  • a common electrode 12 is placed into the frontal bone or other zero level activity point from which to detect levels of normal and abnormal electrical energy created in the brain. This electrode is connected by a conductor 13 to an electronic circuit.
  • the second detecting electrode 14 is placed into one of the critical brain areas such as the eleptogenic lesion portions of the skull 10, while a third electrode 16 is placed into a control point of the brain. This may be in the same area as the detecting electrode or a different area of the brain.
  • Signals from electrode 14 are fed through a conductor 20 to an inverting electronic device 22 which changes the electrical phase of the detected signal in preparation for use by a comparison circuit 24.
  • the signal from the inverter 22 is fed to the comparison circuit through a conductor 26.
  • a reference voltage level R which typically may be about millivolts in the case of a human, is set by the doctor in charge who has determined by appropriate tests the level of voltage in the brain beyond which the patient to which the device is affixed needs a countermotive force brought to action to quell the ensuing anticipated storm.
  • This reference voltage after the level has been established is set and then is fed to the comparison circuit 24 through a conductor 28.
  • the comparison and analog addition circuit 24 will perform a vector addition so that the resultant R-X should be a quantity negative in phase to that of the original detected value X from electrode 14.
  • the resultant is such that X+( R-X) equals the value R, the normal set level.
  • the point of control as compared to the point of detection may be scale factors apart. When this occurs a level set amplifier provides compensation for such a condition.
  • a filter 32 which receives the outputKR-X) from circuit 24 as fed through conductor 34.
  • This filter 32 is used to prevent the electronics of the brain analysis from interfering with other electrical functions such as heart beat and respiration.
  • An oscillator 40 is adapted to generate a high frequency signal which signal is used as a carrier for the feedback information being communicated to the brain point of control.
  • the synaptic chains in the brain have the manifestation of semiconductors in that they act as diode detectors as in a radio circuit the information provided to the snyaptic circuits is oriented in such a manner that the normal operation of the nervous system will now detect the control data at minimum energy level to accomplish the needed reduction of the brain energy at the localized areas and provide an elimination of the excess electrical energy in the brain.
  • Signals from the modulator 30 are sent through conductor 42 to a safety limit circuit 44 which provides standby passive and active networks which act as a limiting fuse to insure and prevent any excessive energy from the said electrical apparatus to be fed to the brain to cause or affect the brain or other nervous system.
  • Signals from the circuit44 to electrode 16 is carried by conductor 46.
  • a battery power supply 50 energizes the circuit and because of the serious nature of this control device and what a deficiency in energization would cause preferably includes a self test circuit with a low limit control 54 and an alarm 56 for extra protection.
  • FIG. 3 there is depicted the normal arrangement and mounting of the apparatus on the patient.
  • the electrodes 12, I4 and 16 are implanted in the brain in the skull 10 of the patient 60 to be treated and controlled.
  • Conductors 13, 20 and 46 carry the signals and controlling voltage to the electronic circuits carried in a small case 62.
  • the components carried by the case are enclosed in phantom outline in FIG. 1. Except for the-battery power which is contemplated to be a small battery, the circuits providing the inverter 22, the
  • filter 32, modulator 30, safety circuit 44, oscillator 40 and self test circuit 54 are all contemplated to be solid state minaturized as much as possible.
  • the reference voltage set is usually an adjustable resistor located within the case and set by key means to prevent an accidental change. It is contemplated that the case 62 when used externally is less than the size of a package of cigarettes. With integrated circuitry the case 62 may be made even smaller for implanting under the skin of the patient 60.
  • Automatic feedback control is the essence of this invention in that this control receives signals indicating aberrant energy from the brain, analyses it electronically as necessary and with a proper safety and power supply means then feeds electric energy back into the brain in opposition to the original aberrant level so that the net resultant voltage, current and/or electrical field in localized areas on the brain is maintained at no level greater than that experienced during normal behavior.
  • the electronicfeedback device of this invention is applied not only to those types of epilepsy where aura is electrically seen prior to an actual seizure (typified by some types of Grand Mal and Temporal Lobe Epilepsy) but also is applied to some types of mental illness where psychic storms occur providing electrical activity in the brain similar to that of epilepsy but having as its manifestations psychic storms instead of physiological seizures.
  • the means of detecting and controlling the voltage level of the brain is through the use of implanted electrodes 12, 14 and 16.
  • the reason for employing implanted electrodes as compared to surface electrodes is to provide the exact point of application in the brain where either the point of detection or the point of control can be found without having the electrical path through the skull either deterioriate the signal in terms of the detection signal due to the impedance of the fluids, tissue, skull bone and other media between such point of detection and an external point.
  • a control signal for feedback data if applied externally, would require a larger electrical signal to produce a comparable control.
  • Typical electrical voltages repre sented in medical research studies reveal that when monitored internally a normal brain pattern signal can reach 10 millivolts while the same signal monitored outside the skull produces a level of approximately 10 microvolts.
  • the aura condition of an epileptic seizure can in fact increase the electrical activity a factor of 10 times to a level 100 millivolts (when monitored internally).
  • a minus millivolts level would be internally applied whereas approximately minus 90 volts would be externally applied; a quantity which could be dangerous. Therefore, in the present invention internal electrodes are to be used so that the voltage control will be at low levels which is safe.
  • the concept of automatic feedback has been used in the field of servo technology for many years.
  • the uniqueness of the present invention is the application of automatic feedback theory and devices wherein the electrical energy of a mammal such as a'human is considered part of a servo loop in the automatic feedback.
  • detected signal from electrode 14 is carried by conductor 20 to an inverting circuit 22 where the signal is reversed in polarity (minus the reference voltage level) in order to be added to the aberrant brain electrical level during the epileptic or psychic storms.
  • This causes the brain voltage to be reduced to that of the reference level.
  • This action is similar to that of adding several voltages together in an analog computer at a summing junction where the resultant electrical levels are the algebraic sum of all voltages added at that point. This, of course, takes into consideration the sign or phase of the voltages being added.
  • the common or ground electrode 12 is used as a reference point against which the electrical levels at the point of detection, the point of control and all other computing reference and safety electrical levels is judged and conditioned.
  • the inverted signal X from circuit 22 is carried by conductor 26 to the comparison and analog addition circuit 24. Also to electronic circuit 24 is fed signal R which is carried by conductor 28 and is the reference voltage level set by the doctor. Another signal is the brain signal from the common electrode 12 which is fed to this comparison circuit.
  • Direct current power to operate the electronic circuitry is derived from the power supply 50 which has its own related safety and self-test circuitry 54 which when used as a permanently installed unit includes a low limit alarm 56 which indicates when a malfunction or voltage loss occurs.
  • the comparison and analog addition circuitry 24 receives the inverted signal X from conductor 26 and combines this algebraically with signal R carried by conductor 28 so that the electrical quantity R-X is produced as a raw signal yet to be conditioned for use as the ultimate feedback signal.
  • This raw signal is fed by conductor 34 to the filter 32 which removes all frequency components which could effect vital functions such as respiration and heart action.
  • the frequency band usable for these functions is approximately 5 to 40 herz.
  • the signal entering the modulation and level set amplifier 30 is the electrical quantity R-X limited within the frequencies of F to F2 (approximately 5 to herz).
  • the oscillator 40 and modulator level set amplifier 30 are both operated from the same battery power supply 50, noted above.
  • the oscillator generates a high frequency carrier signal wherein there is created a selected frequency having a range from 40,000 herz to 1 million herz.
  • the need to use a high frequency carrier is so as to utilize 6 the lowest voltage possible in the carrier electrical signals and also to utilize the inherent electrical phenomenon manifest in the synapsis of the brain. Since the electrical nerve pathways in the body are-really c0mposed of synapsis which react to provide electrical energy transfer similar to the semiconductor devices called diodes the operator of the device is able to forecast the utilization of these synaptic pathways as diode detectors.
  • the diode characteristic which is used in radio circuits to separate the audio information from the high frequency carrier signal is like the present circuit of this invention where it is planned to use the conditioned feedback signal to detect and provide for brain control utilizing the brain synapsis.
  • the brain synapsis is emloyed to demodulate the correct data from the high frequency carrier which by itself is not seen by the rest of the body.
  • the level set amplifier, 30 is set by the doctor so that the particular mammal being treated has the determined electrical levels set to compensate for the particular levels required to stablize the brain activity of that mammal. If the control signal is fed back into the same area from which the electrode received signals are set, the voltage is likely to be at unity value with respect to the originating signal.
  • the modulator 30 receives the high frequency signal generated by the oscillator 40 and impinges on the signal the envelope of frequencies entering the modulator and level set amplifier 30. These frequencies include the electrical signal quantity R-X filtered from F1 to F2 by filter 32 which modulates in amplitude the high frequency signal. The resulting conditioned electrical signal is sent by conductor 42 to the safety limit circuit 44.
  • This safety limit circuit 44 provides additional electrical safeguards to prevent either momentary or long term pulses or continuous electrical signals from developing to a level which will be injurious to the mammal involved.
  • the electronic circuit acts at a rate which is responsive and available to assist the physiological needs of the mammal.
  • Self-test circuit 54 is designed to assure the mammal, when human, to which this device is connected that the electronic circuit is in an operative condition ready for activiation without any jeopardy of the operation arising from low battery voltage.
  • the initial electronics and power source (battery and control safety circuits) will occupy a volume less than a pack of standard cigarettes and be externally carried on the user.
  • the electronics and power source be mounted beneath the skin surface of the user in the form of a small wafer.
  • Apparatus for monitoring, analyzing and when required counteracting excess brain electrical energy of a patient to prevent epileptic seizures and the like said apparatus including: (a) three electrodes adapted to be implanted in the brain being monitored, each electrode connected through conductors to a constantly ener gized and connected electronic circuit, said electrodes including a first implantable electrode adapted to be placed in a zero activity point of the brain, the electrical output from this first electrode detecting the levels of normal and abnormal electrical energy and feeding this output as a signal to the electronics circuit portion of the apparatus, a second implantable electrode adapted to be placed in a typical point of detection area of the brain, the output from this electrode sent as a signal from this area to the electronic circuit, and a third implantable electrode adapted to be placed in a typical point of control of the same brain, this electrode receiving countermotive forces from the electronic circuit when said circuit so determines; (b) an electronic means and an amplifier means in said electronic circuit, said electronic means receiving the output of the implantable second electrode and inverting this output after
  • Apparatus for monitoring and counteracting excess brain electrical energy as in claim 1 in which the power means is a battery whose energy level is monitored by a self .test circuit means and there is additionally circuit means connected to said power means providing a limit control and an alarm which is actuated when the voltage drops below that set by the limit control.
  • Apparatus for monitoring and counteracting excess brain electrical energy as in claim 2 in which there is provided an oscillator which generates a high frequency signal connected to the circuit means for receiving and monitoring the signal from the comparison and addition circuit, this high frequency signal being used as a carrier for a feedback signal when such a signal is sent to the third electrode.
  • the electronic circuit includes a filter connected between said comparison and analog addition means and said circuit means for receiving and monitoring the signal from the comparison and analog addition means which receives the signal output from electronic circuit means providing the comparison and analog addition function and filters the electronic flow to prevent this flow from interfering with other electrical brain functions such as heart beat and respiration, said filtered signal being conducted and fed to the circuit means for receiving and monitoring the signal from the comparison and addition circuit means.
  • Apparatus for monitoring and counteracting excess brain electrical energy as in claim 4 in which the electrodes are adapted to be permanently implanted and the electronics and battery therefore are encased so as to provide a small size unit which may be easily carried on and by the body of the one being monitored.
  • a method for monitoring and counteracting excess brain electrical energy to prevent epileptic seizures which includes the steps of: (a) implanting three electrodes in the brain of the mammal being monitored, the first electrode being placed in a zero activity point of the brain and from this electrode feeding its electrical output to a constantly energized and connected electronic circuit, the second electrode being placed in a typical point of detection area of the brain and a third electrode being placed in a typical point of control of the same brain; (b) connecting the electronic circuit to the second electrode by a conductor and inverting electronically the output of the brain from this second electrode and feeding the resulting inverted signal to an electronic means in said circuit to provide a comparison and addition means to incoming signals; (0) connecting a conductor to the first electrode which carries the electrical energy level of the zero activity in the brain, this electrical energy being fed to the comparison circuit for analysis of the energy in relation to a normal energy level; (cl) setting by the one in charge of the apparatus a reference voltage control level, this reference voltage being fed to the electronic means providing the comparison, said means
  • the method for monitoring and counteracting excess brain electrical energy as in claim 7 which includes the further step of connecting an oscillator which generates a high frequency signal so as to feed said oscillating signal to the level set amplifier portion of the electronic circuit with this high frequency signal'providing a carrier for the feedback signal to the third electrode.
  • the method for monitoring and counteracting excess brain electrical energy as in claim 8 which includes the step of providing a filter which receives the signal output from the electronic means providing the comparison and analog addition and filters the electronic current therefrom to prevent this current signal from interfering with other electrical brain functions such as the heart beat and respiration and feeding said filtered signal to the level set amplifier portion of the electronic circuit.
  • the method for monitoring and counteracting excess brain electrical energy as in claim 9 which includes permanently implanting the electrodes and further includes encasing the electronics and battery to provide a small unit which may be easily carried on the body of the one monitored.

Abstract

This invention pertains to a biomedical detecting and control apparatus wherein electrical signals in the brain of mammals are continuously monitored by electrodes implanted in certain critical places in the brain wherein excess electrical energy is manifest during epileptic seizure conditions as well as during psychic storms of some types of mental illness. Such signals are processed via electrical systems of various circuits for inversion, comparison, vector analog addition, filtering, modulation, level set, safety level limits and self test to provide a controlled signal output which automatically reduces or eliminates the excess electrical energy at the point of detection. The points of detection and control may be, but do not have to be, the same spots on the brain. The probes may be near the surface of the brain or deep set in the brain depending upon the area affected. In addition to the method, there is described an electronic device which is contemplated to be housed in a small housing outside the body of the mammal and connected through wire conductors connected to the electrodes at the point of detection and at the other end of the conductors to outlet connectors in the housing providing the point of control.

Description

United States Patent [1 1 Liss [ Nov. 26, 1974 METHOD AND APPARATUS FOR MONITORING AND COUNTERACTING EXCESS BRAIN ELECTRICAL ENERGY TO PREVENT EPILEPTIC SEIZURES AND THE LIKE [76] Inventor: Saul Liss, 555 E. 27th St., Paterson,
[22] Filed: Apr. 9, 1973 [21] Appl. No.: 348,864
[52] US. Cl 128/2.1 R, 128/419 S, 128/422 [51] Int. Cl. A61b 5/04, A61n 1/00 [58] Field of Search 128/2.l R, 2.1 B, 2.1 P,
l28/2.1 Z, 2.06 D, 419 R, 419 S, 422, l C, 410
[56] References Cited UNITED STATES PATENTS 3,032,029 5/1962 Cunningham l28/2.l R 3,495,596 2/1970 Condict l28/l C 3,510,765 5/1970 Baessler A 128/2.06 A 3,513,834 5/1970 Suzuki et al. .1 l28/2.l 8 3,587,563 6/1971 Ragsdale......... 128/206 A 3,699,970 10/1972 Brindey et a1 128/419 R OTHER PUBLICATIONS John Osmundson, Matador with Radio Stops Wired Bull New York Times Newspaper, pg. 1 8!. 20,
Primary Examiner Richard A. Gaudet Assistant ExaminerLee S. Cohen Attorney, Agent, or FirmRalph R. Roberts [57] ABSTRACT This invention pertains to a biomedical detecting and control apparatus wherein electrical signals in the brain of mammals are continuously monitored by electrodes implanted in certain critical places in the brain wherein excess electrical energy is manifest during epileptic seizure conditions as well as during psychic storms of some types of mental illness. Such signals are processed via electrical systems of various circuits for inversion, comparison, vector analog addition, filtering, modulation, level set, safety level limits and self test to provide a controlled signal output which automatically reduces or eliminates the excess electrical energy at the point of detection. The points of detection and control may be, but do not have to be, the same spots on the brain. The probes may be near the surface of the brain or deep set in the brain depending upon the area affected. In addition to the method, there is described an electronic device which is contemplated to be housed in a small housing outside the body of the mammal and connected through wire conductors connected to the electrodes at the point of detection and at the other end of the conductors to outlet connectors in the housing providing the point of control.
10 Claims, 3 Drawing Figures 2 26, i 34 7 F1 1 44 i INVERTING I COMPA -x F i i ELECTRONICS g (Ft-x); E 1 MODULATOR SAFETY ADDITION CIRCUIT F'LTER a LEVEL ser 42 emu, AMPLIFIER 22 BRAIN common I I ELECTRODE I i OUTPUT 'I3 R F28 C 46 1 I I I4 0 /I6 l 7 I REFERENC BATTERY I0 LEVEL POWER s51- av SUPPLY OSCILLATOR oocron *H 54 5s 62/)! SELF rssr CIRCUIT WITH :ZZ' H CONTROL LOW LIMIT PATENTEDHUVEBISM 3 5 sum 2 BF 2 TYPICAL POIN T OF DETECTION TYPICAL PomT 6 OF CONTROL METHOD AND APPARATUS FOR MONITORING AND COUNTERACTING EXCESS BRAIN ELECTRICAL ENERGY TO PREVENT EPILEPTIC SEIZURES AND THE LIKE BACKGROUND OF THE INVENTION 1. Field of the Invention With reference to the classification of art as established in the US. Patent Office the present invention pertains to art found in the Class entitled, Surgery (Class 128) and the subclass of pulsating and alternating electric circuits (subclass 421).
2. Description of the Prior Art Many patents are directed toward analysis of and conditions causing mental illness. These studies of mammal brains and the resulting behaviors have confirmed that electrical impulses within the brain cause predicted results in parts of the body associated with specific areas of the brain. Among these patents are US. Pat. No. 3,495,596 to CONDICT as issued on Feb. 17, 1970; U.S. Pat. No. 2,368,207 to EATON as issued on Jan. 30, 1945 and US. Pat. No. 2,473,378 to LIB ERSON as issued on June 14, 1949.
As a result of these studies of mammals, including humans, it has been found that there are certain types of epilepsy and psychic diseases (mental illness) wherein an aura condition exists prior to the happening of an epileptic or psychic storm. During that period of time it has been found that the level of electrical activity rises by a magnitude of 5 to times the normal 10 millivolt level typically found in the average human brain. The frequency of the brain signals change from 5 to 8 herz down to one-half to one herz. During this storm period in particular areas of the brain, the pattern of electrical activity or irregularity can spread to other various spots and areas of the brain much in the way worn electrical insulation may give way to excess electrical potential causing an electrical discharge either locally or in large areas depending on the specific characteristics of insulation and voltage application. Just as electrical systems of extreme precision are protected and controlled by regulators, filters, fuses, etc. so also is it a purpose of this device to counteract automatically any excess electrical energy in the brain at the spots being monitored and detected.
Cases have been reported wherein olfactory senses have been utilized to overcome the aura effect and by this means prevent the consequential seizure. This has produced a belief that, at least in some cases, the electrical energy in the brain indicated by such reaction can be duplicated under controlled conditions and can be used to control a brain center other than at the place at which the excessive aberrant energy is resent. Hence, the method and present. of this invention contemplates conditions where implanted electrodes for detection and control may be placed in selected parts of the brain not directly involved with the excessive pattern.
Temporal lobe epilepsy is a typical disease where it is believed to be necessary to provide deep implanted electrodes; first of all to detect the electrical presence of the aberrant energy and second of all to counteract locally this excessive aberrant energy. The method and apparatus of this invention is intended to provide the detection means and the electrical signals necessary to counteract and restrain these excesses.
SUMMARY OF THE INVENTION This invention may be summarized at least in part with reference to its objects. It is an object of this invention to provide both the method and the means of monitoring the brain of a mammal by means of permanently inserted electrodes in selected critical areas of the brain. By connecting these electrodes to a monitoring device, safety limits for brain signal outputs can be evaluated and upon indications of excess outputs counteracting signals can be fed to the brain to prevent aberrant activity as produced in certain mental illness conditions and epilepsy seizures.
In addition to the above summary the following disclosure is detailed to insure adequacy and aid in understanding of the invention. This disclosure, however, is not intended to prejudice that purpose of a patent which is to cover each new inventive concept therein no matter how it may later be disguised by variations,
in form or additions of further improvements. For this reason there has been chosen a specific circuit diagram showing a means of employing the signals within a brain of a mammal and by monitoring and counteracting excessive energy showing a preferred means for preventing these excesses. This specific embodiment has been chosen for the purposes of illustration and description as shown in the accompanying drawings wherein:
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 3 represents a diagram showing the attachment of and the support of the apparatus to and by a human.
In the following description and in the claims various details will be identified by specific names for convenience, these names, however, are intended to be generic in their application. Corresponding reference characters refer to like members throughout the three figures of the drawings.
The drawings accompanying, and forming part of, this specification disclose certain details for the purpose of explanation of the broader aspects of the invention, but it should be understood that details may be modified without departure from the concept of the invention and that the invention may be incorporated in other structural forms than shown.
PRINCIPLE OF OPERATION AS, SEEN IN THE ASSOCIATED BLCXIK DIAGRAM In the skull or head 10 of the mammal a common electrode 12 is placed into the frontal bone or other zero level activity point from which to detect levels of normal and abnormal electrical energy created in the brain. This electrode is connected by a conductor 13 to an electronic circuit.
The second detecting electrode 14 is placed into one of the critical brain areas such as the eleptogenic lesion portions of the skull 10, while a third electrode 16 is placed into a control point of the brain. This may be in the same area as the detecting electrode or a different area of the brain.
Signals from electrode 14 are fed through a conductor 20 to an inverting electronic device 22 which changes the electrical phase of the detected signal in preparation for use by a comparison circuit 24. The signal from the inverter 22 is fed to the comparison circuit through a conductor 26.
A reference voltage level R, which typically may be about millivolts in the case of a human, is set by the doctor in charge who has determined by appropriate tests the level of voltage in the brain beyond which the patient to which the device is affixed needs a countermotive force brought to action to quell the ensuing anticipated storm. This reference voltage after the level has been established is set and then is fed to the comparison circuit 24 through a conductor 28.
The comparison and analog addition circuit 24 will perform a vector addition so that the resultant R-X should be a quantity negative in phase to that of the original detected value X from electrode 14. The resultant is such that X+( R-X) equals the value R, the normal set level. However, it may be found that the point of control as compared to the point of detection may be scale factors apart. When this occurs a level set amplifier provides compensation for such a condition.
Between the output from comparison circuit 24 which is fed to amplifier 30 is a filter 32 which receives the outputKR-X) from circuit 24 as fed through conductor 34. This filter 32 is used to prevent the electronics of the brain analysis from interfering with other electrical functions such as heart beat and respiration. An oscillator 40 is adapted to generate a high frequency signal which signal is used as a carrier for the feedback information being communicated to the brain point of control.
Since the synaptic chains (in the brain) have the manifestation of semiconductors in that they act as diode detectors as in a radio circuit the information provided to the snyaptic circuits is oriented in such a manner that the normal operation of the nervous system will now detect the control data at minimum energy level to accomplish the needed reduction of the brain energy at the localized areas and provide an elimination of the excess electrical energy in the brain.
Signals from the modulator 30 are sent through conductor 42 to a safety limit circuit 44 which provides standby passive and active networks which act as a limiting fuse to insure and prevent any excessive energy from the said electrical apparatus to be fed to the brain to cause or affect the brain or other nervous system. Signals from the circuit44 to electrode 16 is carried by conductor 46. A battery power supply 50 energizes the circuit and because of the serious nature of this control device and what a deficiency in energization would cause preferably includes a self test circuit with a low limit control 54 and an alarm 56 for extra protection.
Referring next to FIG. 3, there is depicted the normal arrangement and mounting of the apparatus on the patient. The electrodes 12, I4 and 16 are implanted in the brain in the skull 10 of the patient 60 to be treated and controlled. Conductors 13, 20 and 46 carry the signals and controlling voltage to the electronic circuits carried in a small case 62. The components carried by the case are enclosed in phantom outline in FIG. 1. Except for the-battery power which is contemplated to be a small battery, the circuits providing the inverter 22, the
comparison and analog addition 24, filter 32, modulator 30, safety circuit 44, oscillator 40 and self test circuit 54 are all contemplated to be solid state minaturized as much as possible. The reference voltage set is usually an adjustable resistor located within the case and set by key means to prevent an accidental change. It is contemplated that the case 62 when used externally is less than the size of a package of cigarettes. With integrated circuitry the case 62 may be made even smaller for implanting under the skin of the patient 60.
USE AND OPERATION Automatic feedback control is the essence of this invention in that this control receives signals indicating aberrant energy from the brain, analyses it electronically as necessary and with a proper safety and power supply means then feeds electric energy back into the brain in opposition to the original aberrant level so that the net resultant voltage, current and/or electrical field in localized areas on the brain is maintained at no level greater than that experienced during normal behavior. The electronicfeedback device of this invention is applied not only to those types of epilepsy where aura is electrically seen prior to an actual seizure (typified by some types of Grand Mal and Temporal Lobe Epilepsy) but also is applied to some types of mental illness where psychic storms occur providing electrical activity in the brain similar to that of epilepsy but having as its manifestations psychic storms instead of physiological seizures.
The means of detecting and controlling the voltage level of the brain is through the use of implanted electrodes 12, 14 and 16. The reason for employing implanted electrodes as compared to surface electrodes is to provide the exact point of application in the brain where either the point of detection or the point of control can be found without having the electrical path through the skull either deterioriate the signal in terms of the detection signal due to the impedance of the fluids, tissue, skull bone and other media between such point of detection and an external point. Similarly, a control signal for feedback data, if applied externally, would require a larger electrical signal to produce a comparable control. Typical electrical voltages repre sented in medical research studies reveal that when monitored internally a normal brain pattern signal can reach 10 millivolts while the same signal monitored outside the skull produces a level of approximately 10 microvolts.
The aura condition of an epileptic seizure can in fact increase the electrical activity a factor of 10 times to a level 100 millivolts (when monitored internally). Hence, for a corrective signal to be applied in opposition to such an aberrant level, a minus millivolts level would be internally applied whereas approximately minus 90 volts would be externally applied; a quantity which could be dangerous. Therefore, in the present invention internal electrodes are to be used so that the voltage control will be at low levels which is safe.
The concept of automatic feedback has been used in the field of servo technology for many years. The uniqueness of the present invention is the application of automatic feedback theory and devices wherein the electrical energy of a mammal such as a'human is considered part of a servo loop in the automatic feedback.
The normalizing of this current flow provides a resultant improvement in the mammals performance where without such feedback control afflictions such as epilepsy and mental illness prevent the normal behavior of that particular mammal and the resulting deterioration caused by the affliction.
The employment of this system requires implanted electrodes, transdermal wires and external electronics. It is noted that just as history with heart pacemakers has shown that totally implanted devices can be made practical, so also is it anticipated that this device with sufiicient experience and history will be implanted with the application of electronic miniaturization. The miniature electronic detection and control device of this invention will be capable of being totally implanted thus eliminating transdermal wire with the inherent possibility of damage and failure of the system.
In use, detected signal from electrode 14 is carried by conductor 20 to an inverting circuit 22 where the signal is reversed in polarity (minus the reference voltage level) in order to be added to the aberrant brain electrical level during the epileptic or psychic storms. This causes the brain voltage to be reduced to that of the reference level. This action is similar to that of adding several voltages together in an analog computer at a summing junction where the resultant electrical levels are the algebraic sum of all voltages added at that point. This, of course, takes into consideration the sign or phase of the voltages being added.
The common or ground electrode 12 is used as a reference point against which the electrical levels at the point of detection, the point of control and all other computing reference and safety electrical levels is judged and conditioned.
The inverted signal X from circuit 22 is carried by conductor 26 to the comparison and analog addition circuit 24. Also to electronic circuit 24 is fed signal R which is carried by conductor 28 and is the reference voltage level set by the doctor. Another signal is the brain signal from the common electrode 12 which is fed to this comparison circuit. Direct current power to operate the electronic circuitry is derived from the power supply 50 which has its own related safety and self-test circuitry 54 which when used as a permanently installed unit includes a low limit alarm 56 which indicates when a malfunction or voltage loss occurs.
The comparison and analog addition circuitry 24 receives the inverted signal X from conductor 26 and combines this algebraically with signal R carried by conductor 28 so that the electrical quantity R-X is produced as a raw signal yet to be conditioned for use as the ultimate feedback signal. This raw signal is fed by conductor 34 to the filter 32 which removes all frequency components which could effect vital functions such as respiration and heart action. The frequency band usable for these functions is approximately 5 to 40 herz. The signal entering the modulation and level set amplifier 30 is the electrical quantity R-X limited within the frequencies of F to F2 (approximately 5 to herz).
The oscillator 40 and modulator level set amplifier 30 are both operated from the same battery power supply 50, noted above.
The oscillator generates a high frequency carrier signal wherein there is created a selected frequency having a range from 40,000 herz to 1 million herz. The need to use a high frequency carrier is so as to utilize 6 the lowest voltage possible in the carrier electrical signals and also to utilize the inherent electrical phenomenon manifest in the synapsis of the brain. Since the electrical nerve pathways in the body are-really c0mposed of synapsis which react to provide electrical energy transfer similar to the semiconductor devices called diodes the operator of the device is able to forecast the utilization of these synaptic pathways as diode detectors. This means that the diode characteristic which is used in radio circuits to separate the audio information from the high frequency carrier signal is like the present circuit of this invention where it is planned to use the conditioned feedback signal to detect and provide for brain control utilizing the brain synapsis. The brain synapsis is emloyed to demodulate the correct data from the high frequency carrier which by itself is not seen by the rest of the body. The level set amplifier, 30 is set by the doctor so that the particular mammal being treated has the determined electrical levels set to compensate for the particular levels required to stablize the brain activity of that mammal. If the control signal is fed back into the same area from which the electrode received signals are set, the voltage is likely to be at unity value with respect to the originating signal. However, when it is necessary to apply the control signal at a point of control which is different from the point of detection by the electrodes it will be required to use a ratio scale to increase or decrease the control signal experimentally to determine that signal level necessary at the point of control which is required to quell or stabilize the detected aberrant energy in the brain.
The modulator 30 receives the high frequency signal generated by the oscillator 40 and impinges on the signal the envelope of frequencies entering the modulator and level set amplifier 30. These frequencies include the electrical signal quantity R-X filtered from F1 to F2 by filter 32 which modulates in amplitude the high frequency signal. The resulting conditioned electrical signal is sent by conductor 42 to the safety limit circuit 44.
This safety limit circuit 44 provides additional electrical safeguards to prevent either momentary or long term pulses or continuous electrical signals from developing to a level which will be injurious to the mammal involved. As the time constant of energy of the physiological mammal is in terms of milliseconds and the electrical condition and functioning of the control circuit is in terms of microseconds, the electronic circuit acts at a rate which is responsive and available to assist the physiological needs of the mammal.
Self-test circuit 54 is designed to assure the mammal, when human, to which this device is connected that the electronic circuit is in an operative condition ready for activiation without any jeopardy of the operation arising from low battery voltage.
It is anticipated, as above noted, that the initial electronics and power source (battery and control safety circuits) will occupy a volume less than a pack of standard cigarettes and be externally carried on the user. With the use of micro electronics it is further anticipated that this size can ultimately be further reduced and the electronics and power source be mounted beneath the skin surface of the user in the form of a small wafer.
Terms such as left," right, up, down," bottom," top, front, back, in, out and the like are applicable to the embodiment shown and described in conjunction with the drawings. These terms are merely for the purpose of description and do not necessarily apply to the position in which the apparatus for monitoring and counteracting excess brain energy may be constructed or used.
While this particular embodiment of the apparatus and method of use has been shown and described it is to be'understood the invention is not limited thereto since modifications may be made within the scope of the accompanying claims and protection is sought to the broadest extent the prior art allows.
What is claimed is:
1. Apparatus for monitoring, analyzing and when required counteracting excess brain electrical energy of a patient to prevent epileptic seizures and the like, said apparatus including: (a) three electrodes adapted to be implanted in the brain being monitored, each electrode connected through conductors to a constantly ener gized and connected electronic circuit, said electrodes including a first implantable electrode adapted to be placed in a zero activity point of the brain, the electrical output from this first electrode detecting the levels of normal and abnormal electrical energy and feeding this output as a signal to the electronics circuit portion of the apparatus, a second implantable electrode adapted to be placed in a typical point of detection area of the brain, the output from this electrode sent as a signal from this area to the electronic circuit, and a third implantable electrode adapted to be placed in a typical point of control of the same brain, this electrode receiving countermotive forces from the electronic circuit when said circuit so determines; (b) an electronic means and an amplifier means in said electronic circuit, said electronic means receiving the output of the implantable second electrode and inverting this output after which the resulting electrical signal is fed to said amplifier means of the electronic circuit, said amplifier means providing a comparison and addition means to incoming signals; (c) a conductor connected to the first electrode, said conductor being connected to said amplifier means and carrying the electrical energy level of the zero activity portion of the brain to the amplifier which analyzes and compares this energy level in rela tion to previously established normal; (d) means for sending a reference voltage to the amplifier comparison and addition circuit, this reference voltage established and set by the operator in accordance to previously determined electrical thresholds of the brain of the patient in which the electrodes are to be implanted, this reference voltage being compared by and in said amplifier circuit and where necessary a vector addition is made by this amplifier circuit to add voltage to the inverted received voltage; (e) a circuit means in the electronic circuit for receiving and monitoring the signal from the comparison and addition circuit means and when this signal exceeds a set level amplifies this signal a determined amount; (f) a circuit means providing both passive and active electronic network means for receiving the monitored and amplified signal indicative of excess energy outputs from the second electrode and within predetermined maximum limits provides a countermotive force which is sent through a conductor to the third electrode which force quells this storm in the brain, and (g) a power means connected to the electrical circuit to supply a constantly on" power necessary to energize the electrical circuit to normal operating levels.
2. Apparatus for monitoring and counteracting excess brain electrical energy as in claim 1 in which the power means is a battery whose energy level is monitored by a self .test circuit means and there is additionally circuit means connected to said power means providing a limit control and an alarm which is actuated when the voltage drops below that set by the limit control.
3. Apparatus for monitoring and counteracting excess brain electrical energy as in claim 2 in which there is provided an oscillator which generates a high frequency signal connected to the circuit means for receiving and monitoring the signal from the comparison and addition circuit, this high frequency signal being used as a carrier for a feedback signal when such a signal is sent to the third electrode.
4. Apparatus for monitoring and counteracting excess brain electrical energy as in claim 3 in which the electronic circuit includes a filter connected between said comparison and analog addition means and said circuit means for receiving and monitoring the signal from the comparison and analog addition means which receives the signal output from electronic circuit means providing the comparison and analog addition function and filters the electronic flow to prevent this flow from interfering with other electrical brain functions such as heart beat and respiration, said filtered signal being conducted and fed to the circuit means for receiving and monitoring the signal from the comparison and addition circuit means.
5. Apparatus for monitoring and counteracting excess brain electrical energy as in claim 4 in which the electrodes are adapted to be permanently implanted and the electronics and battery therefore are encased so as to provide a small size unit which may be easily carried on and by the body of the one being monitored.
6. A method for monitoring and counteracting excess brain electrical energy to prevent epileptic seizures which includes the steps of: (a) implanting three electrodes in the brain of the mammal being monitored, the first electrode being placed in a zero activity point of the brain and from this electrode feeding its electrical output to a constantly energized and connected electronic circuit, the second electrode being placed in a typical point of detection area of the brain and a third electrode being placed in a typical point of control of the same brain; (b) connecting the electronic circuit to the second electrode by a conductor and inverting electronically the output of the brain from this second electrode and feeding the resulting inverted signal to an electronic means in said circuit to provide a comparison and addition means to incoming signals; (0) connecting a conductor to the first electrode which carries the electrical energy level of the zero activity in the brain, this electrical energy being fed to the comparison circuit for analysis of the energy in relation to a normal energy level; (cl) setting by the one in charge of the apparatus a reference voltage control level, this reference voltage being fed to the electronic means providing the comparison, said means performing vector addition when necessary; (e) feeding the output signal current of the addition means to a level set amplifier portion of the electronic circuit, which, when necessary, amplifies this current signal; (f) sending the signal cess brain electrical energy as in claim 6 in which the step of providing the power means is a battery whose energy level is monitored by a self-test circuit having a low voltage limit control and an alarm.
8. The method for monitoring and counteracting excess brain electrical energy as in claim 7 which includes the further step of connecting an oscillator which generates a high frequency signal so as to feed said oscillating signal to the level set amplifier portion of the electronic circuit with this high frequency signal'providing a carrier for the feedback signal to the third electrode.
9. The method for monitoring and counteracting excess brain electrical energy as in claim 8 which includes the step of providing a filter which receives the signal output from the electronic means providing the comparison and analog addition and filters the electronic current therefrom to prevent this current signal from interfering with other electrical brain functions such as the heart beat and respiration and feeding said filtered signal to the level set amplifier portion of the electronic circuit.
10. The method for monitoring and counteracting excess brain electrical energy as in claim 9 which includes permanently implanting the electrodes and further includes encasing the electronics and battery to provide a small unit which may be easily carried on the body of the one monitored.

Claims (10)

1. Apparatus for monitoring, analyzing and when required counteracting excess brain electrical energy of a patient to prevent epileptic seizures and the like, said apparatus including: (a) three electrodes adapted to be implanted in the brain being monitored, each electrode connected through conductors to a constantly energized and connected electronic circuit, said electrodes including a first implantable electrode adapted to be placed in a zero activity point of the brain, the electrical output from this first electrode detecting the levels of normal and abnormal electrical energy and feeding this output as a signal to the electronics circuit portion of the apparatus, a second implantable electrode adapted to be placed in a typical point of detection area of the brain, the output from this electrode sent as a signal from This area to the electronic circuit, and a third implantable electrode adapted to be placed in a typical point of control of the same brain, this electrode receiving countermotive forces from the electronic circuit when said circuit so determines; (b) an electronic means and an amplifier means in said electronic circuit, said electronic means receiving the output of the implantable second electrode and inverting this output after which the resulting electrical signal is fed to said amplifier means of the electronic circuit, said amplifier means providing a comparison and addition means to incoming signals; (c) a conductor connected to the first electrode, said conductor being connected to said amplifier means and carrying the electrical energy level of the zero activity portion of the brain to the amplifier which analyzes and compares this energy level in relation to previously established normal; (d) means for sending a reference voltage to the amplifier comparison and addition circuit, this reference voltage established and set by the operator in accordance to previously determined electrical thresholds of the brain of the patient in which the electrodes are to be implanted, this reference voltage being compared by and in said amplifier circuit and where necessary a vector addition is made by this amplifier circuit to add voltage to the inverted received voltage; (e) a circuit means in the electronic circuit for receiving and monitoring the signal from the comparison and addition circuit means and when this signal exceeds a set level amplifies this signal a determined amount; (f) a circuit means providing both passive and active electronic network means for receiving the monitored and amplified signal indicative of excess energy outputs from the second electrode and within predetermined maximum limits provides a countermotive force which is sent through a conductor to the third electrode which force quells this storm in the brain, and (g) a power means connected to the electrical circuit to supply a constantly ''''on'''' power necessary to energize the electrical circuit to normal operating levels.
2. Apparatus for monitoring and counteracting excess brain electrical energy as in claim 1 in which the power means is a battery whose energy level is monitored by a self test circuit means and there is additionally circuit means connected to said power means providing a limit control and an alarm which is actuated when the voltage drops below that set by the limit control.
3. Apparatus for monitoring and counteracting excess brain electrical energy as in claim 2 in which there is provided an oscillator which generates a high frequency signal connected to the circuit means for receiving and monitoring the signal from the comparison and addition circuit, this high frequency signal being used as a carrier for a feedback signal when such a signal is sent to the third electrode.
4. Apparatus for monitoring and counteracting excess brain electrical energy as in claim 3 in which the electronic circuit includes a filter connected between said comparison and analog addition means and said circuit means for receiving and monitoring the signal from the comparison and analog addition means which receives the signal output from electronic circuit means providing the comparison and analog addition function and filters the electronic flow to prevent this flow from interfering with other electrical brain functions such as heart beat and respiration, said filtered signal being conducted and fed to the circuit means for receiving and monitoring the signal from the comparison and addition circuit means.
5. Apparatus for monitoring and counteracting excess brain electrical energy as in claim 4 in which the electrodes are adapted to be permanently implanted and the electronics and battery therefore are encased so as to provide a small size unit which may be easily carried on and by the body of the one being monitored.
6. A method for monitoring and counteracting excess brain electrical energy to prevent epileptic seizures which includes the steps of: (a) implanting three electrodes in the brain of the mammal being monitored, the first electrode being placed in a zero activity point of the brain and from this electrode feeding its electrical output to a constantly energized and connected electronic circuit, the second electrode being placed in a typical point of detection area of the brain and a third electrode being placed in a typical point of control of the same brain; (b) connecting the electronic circuit to the second electrode by a conductor and inverting electronically the output of the brain from this second electrode and feeding the resulting inverted signal to an electronic means in said circuit to provide a comparison and addition means to incoming signals; (c) connecting a conductor to the first electrode which carries the electrical energy level of the zero activity in the brain, this electrical energy being fed to the comparison circuit for analysis of the energy in relation to a normal energy level; (d) setting by the one in charge of the apparatus a reference voltage control level, this reference voltage being fed to the electronic means providing the comparison, said means performing vector addition when necessary; (e) feeding the output signal current of the addition means to a level set amplifier portion of the electronic circuit, which, when necessary, amplifies this current signal; (f) sending the signal from the level set amplifier to a safety limit circuit portion of the electronic circuit, this portion providing passive and active electronic networks which receive this signal and in the cases of excessive energy outputs from the second electrode and the comparison circuit feeds a countermotive force to the third electrode to quell an anticipated storm in the brain, and (g) providing a power means which enables the electronic circuit portion of the apparatus to be constantly energized.
7. The method for monitoring and counteracting excess brain electrical energy as in claim 6 in which the step of providing the power means is a battery whose energy level is monitored by a self-test circuit having a low voltage limit control and an alarm.
8. The method for monitoring and counteracting excess brain electrical energy as in claim 7 which includes the further step of connecting an oscillator which generates a high frequency signal so as to feed said oscillating signal to the level set amplifier portion of the electronic circuit with this high frequency signal providing a carrier for the feedback signal to the third electrode.
9. The method for monitoring and counteracting excess brain electrical energy as in claim 8 which includes the step of providing a filter which receives the signal output from the electronic means providing the comparison and analog addition and filters the electronic current therefrom to prevent this current signal from interfering with other electrical brain functions such as the heart beat and respiration and feeding said filtered signal to the level set amplifier portion of the electronic circuit.
10. The method for monitoring and counteracting excess brain electrical energy as in claim 9 which includes permanently implanting the electrodes and further includes encasing the electronics and battery to provide a small unit which may be easily carried on the body of the one monitored.
US00348864A 1973-04-09 1973-04-09 Method and apparatus for monitoring and counteracting excess brain electrical energy to prevent epileptic seizures and the like Expired - Lifetime US3850161A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US00348864A US3850161A (en) 1973-04-09 1973-04-09 Method and apparatus for monitoring and counteracting excess brain electrical energy to prevent epileptic seizures and the like

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00348864A US3850161A (en) 1973-04-09 1973-04-09 Method and apparatus for monitoring and counteracting excess brain electrical energy to prevent epileptic seizures and the like

Publications (1)

Publication Number Publication Date
US3850161A true US3850161A (en) 1974-11-26

Family

ID=23369877

Family Applications (1)

Application Number Title Priority Date Filing Date
US00348864A Expired - Lifetime US3850161A (en) 1973-04-09 1973-04-09 Method and apparatus for monitoring and counteracting excess brain electrical energy to prevent epileptic seizures and the like

Country Status (1)

Country Link
US (1) US3850161A (en)

Cited By (178)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888260A (en) * 1972-06-28 1975-06-10 Univ Johns Hopkins Rechargeable demand inhibited cardiac pacer and tissue stimulator
US3993046A (en) * 1974-11-06 1976-11-23 Heriberto Fernandez Seizure suppression device
US4165750A (en) * 1978-03-18 1979-08-28 Aleev Leonid S Bioelectrically controlled electric stimulator of human muscles
US4230125A (en) * 1979-07-09 1980-10-28 Schneider Daniel E Method and apparatus for effecting the prospective forewarning diagnosis of sudden brain death and heart death and other brain-heart-body growth maladies such as schizophrenia and cancer and the like
US4440160A (en) * 1982-01-19 1984-04-03 The Johns Hopkins University Self-injurious behavior inhibiting system
WO1985001214A1 (en) * 1983-09-16 1985-03-28 Webster Wilton W Jr Electrophysiological switching unit
WO1985001213A1 (en) * 1983-09-14 1985-03-28 Jacob Zabara Neurocybernetic prosthesis
US4524773A (en) * 1983-08-24 1985-06-25 The John Hopkins University Apparatus for inhibiting self-injurious behavior (SIB) in patients
WO1986002567A1 (en) * 1984-10-23 1986-05-09 Zion Foundation Method and apparatus for delivering a prescriptive electrical signal
US4702254A (en) * 1983-09-14 1987-10-27 Jacob Zabara Neurocybernetic prosthesis
US4709700A (en) * 1985-03-11 1987-12-01 Vaclav Hyrman Electro convulsive therapy method
US4867164A (en) * 1983-09-14 1989-09-19 Jacob Zabara Neurocybernetic prosthesis
US4883057A (en) * 1984-05-09 1989-11-28 Research Foundation, The City University Of New York Cathodic electrochemical current arrangement with telemetric application
US5025807A (en) * 1983-09-14 1991-06-25 Jacob Zabara Neurocybernetic prosthesis
US5167229A (en) * 1986-03-24 1992-12-01 Case Western Reserve University Functional neuromuscular stimulation system
US5299569A (en) * 1991-05-03 1994-04-05 Cyberonics, Inc. Treatment of neuropsychiatric disorders by nerve stimulation
US5311876A (en) * 1992-11-18 1994-05-17 The Johns Hopkins University Automatic detection of seizures using electroencephalographic signals
US5349962A (en) * 1993-11-30 1994-09-27 University Of Washington Method and apparatus for detecting epileptic seizures
US5443710A (en) * 1984-05-09 1995-08-22 Research Foundation, The City University Of New York Microelectrodes and their use in a cathodic electrochemical current arrangement with telemetric application
US5522863A (en) * 1992-08-19 1996-06-04 The United States Of America As Represented By The Secretary Of The Navy Pulsating behavior monitoring and modification system for neural networks
US5559498A (en) * 1994-12-30 1996-09-24 Innotek Inc. Combination confinement and remote training system
US5609617A (en) * 1995-02-21 1997-03-11 C. Norman Shealy Method for enhancement of dehydroepiandrosterone
US5683422A (en) * 1996-04-25 1997-11-04 Medtronic, Inc. Method and apparatus for treating neurodegenerative disorders by electrical brain stimulation
US5690681A (en) * 1996-03-29 1997-11-25 Purdue Research Foundation Method and apparatus using vagal stimulation for control of ventricular rate during atrial fibrillation
US5700282A (en) * 1995-10-13 1997-12-23 Zabara; Jacob Heart rhythm stabilization using a neurocybernetic prosthesis
US5707396A (en) * 1996-04-25 1998-01-13 Institute National De La Sante De La Recherche Medicale (Inserm) Method of arresting degeneration of the substantia nigra by high frequency stimulation of subthalamic nucleus
US5713923A (en) * 1996-05-13 1998-02-03 Medtronic, Inc. Techniques for treating epilepsy by brain stimulation and drug infusion
US5713922A (en) * 1996-04-25 1998-02-03 Medtronic, Inc. Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain
US5716377A (en) * 1996-04-25 1998-02-10 Medtronic, Inc. Method of treating movement disorders by brain stimulation
US5743854A (en) * 1994-03-29 1998-04-28 The Regents Of The University Of California Method and apparatus for inducing and localizing epileptiform activity
US5752979A (en) * 1996-11-01 1998-05-19 Medtronic, Inc. Method of controlling epilepsy by brain stimulation
US5797965A (en) * 1994-08-19 1998-08-25 The United States Of America As Represented By The Secretary Of The Navy Suppression of epileptiform activity
US5800474A (en) * 1996-11-01 1998-09-01 Medtronic, Inc. Method of controlling epilepsy by brain stimulation
US5814092A (en) * 1996-04-04 1998-09-29 Medtronic Inc. Neural stimulation techniques with feedback
EP0911061A2 (en) 1997-10-27 1999-04-28 Neuropace, Inc. System for the treatment of neurological disorders
US5938689A (en) * 1998-05-01 1999-08-17 Neuropace, Inc. Electrode configuration for a brain neuropacemaker
US5954758A (en) * 1994-09-06 1999-09-21 Case Western Reserve University Functional neuromuscular stimulation system
US5975085A (en) * 1997-05-01 1999-11-02 Medtronic, Inc. Method of treating schizophrenia by brain stimulation and drug infusion
US5995868A (en) * 1996-01-23 1999-11-30 University Of Kansas System for the prediction, rapid detection, warning, prevention, or control of changes in activity states in the brain of a subject
US6006124A (en) * 1998-05-01 1999-12-21 Neuropace, Inc. Means and method for the placement of brain electrodes
US6018682A (en) * 1998-04-30 2000-01-25 Medtronic, Inc. Implantable seizure warning system
US6023642A (en) * 1997-05-08 2000-02-08 Biogenics Ii, Llc Compact transcutaneous electrical nerve stimulator
US6066163A (en) * 1996-02-02 2000-05-23 John; Michael Sasha Adaptive brain stimulation method and system
US6128537A (en) * 1997-05-01 2000-10-03 Medtronic, Inc Techniques for treating anxiety by brain stimulation and drug infusion
US6161044A (en) * 1998-11-23 2000-12-12 Synaptic Corporation Method and apparatus for treating chronic pain syndromes, tremor, dementia and related disorders and for inducing electroanesthesia using high frequency, high intensity transcutaneous electrical nerve stimulation
US6161045A (en) * 1999-06-01 2000-12-12 Neuropace, Inc. Method for determining stimulation parameters for the treatment of epileptic seizures
US6230049B1 (en) * 1999-08-13 2001-05-08 Neuro Pace, Inc. Integrated system for EEG monitoring and electrical stimulation with a multiplicity of electrodes
US6227203B1 (en) 1998-02-12 2001-05-08 Medtronic, Inc. Techniques for controlling abnormal involuntary movements by brain stimulation and drug infusion
US6304775B1 (en) 1999-09-22 2001-10-16 Leonidas D. Iasemidis Seizure warning and prediction
US20010051819A1 (en) * 1997-10-27 2001-12-13 Fischell Robert E. Implantable apparatus for treating neurological disorders
US6354299B1 (en) 1997-10-27 2002-03-12 Neuropace, Inc. Implantable device for patient communication
US6366813B1 (en) 1998-08-05 2002-04-02 Dilorenzo Daniel J. Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease
US6374140B1 (en) * 1998-04-30 2002-04-16 Medtronic, Inc. Method and apparatus for treating seizure disorders by stimulating the olfactory senses
WO2002038031A2 (en) * 2000-10-30 2002-05-16 Neuropace, Inc. System and method for determining stimulation parameters for the treatment of epileptic seizures
US6459936B2 (en) * 1997-10-27 2002-10-01 Neuropace, Inc. Methods for responsively treating neurological disorders
US6463328B1 (en) * 1996-02-02 2002-10-08 Michael Sasha John Adaptive brain stimulation method and system
US20030018370A1 (en) * 1996-04-04 2003-01-23 Medtronic, Inc. Technique for adjusting the locus of excitation of electrically excitable tissue
US20030114886A1 (en) * 1999-12-07 2003-06-19 Gluckman Bruce J. Adaptive electric field modulation of neural systems
US6594524B2 (en) 2000-12-12 2003-07-15 The Trustees Of The University Of Pennsylvania Adaptive method and apparatus for forecasting and controlling neurological disturbances under a multi-level control
US6606521B2 (en) 2001-07-09 2003-08-12 Neuropace, Inc. Implantable medical lead
US6658287B1 (en) 1998-08-24 2003-12-02 Georgia Tech Research Corporation Method and apparatus for predicting the onset of seizures based on features derived from signals indicative of brain activity
US6665562B2 (en) 1999-12-07 2003-12-16 George Mason University Adaptive electric field modulation of neural systems
US20030236557A1 (en) * 2002-06-20 2003-12-25 Whitehurst Todd K. Cavernous nerve stimulation via unidirectional propagation of action potentials
US20030236558A1 (en) * 2002-06-20 2003-12-25 Whitehurst Todd K. Vagus nerve stimulation via unidirectional propagation of action potentials
US6678548B1 (en) 2000-10-20 2004-01-13 The Trustees Of The University Of Pennsylvania Unified probabilistic framework for predicting and detecting seizure onsets in the brain and multitherapeutic device
US20040015205A1 (en) * 2002-06-20 2004-01-22 Whitehurst Todd K. Implantable microstimulators with programmable multielectrode configuration and uses thereof
US20040015211A1 (en) * 2002-06-04 2004-01-22 Nurmikko Arto V. Optically-connected implants and related systems and methods of use
US20040015204A1 (en) * 2002-06-20 2004-01-22 Whitehurst Todd K. Implantable microstimulators and methods for unidirectional propagation of action potentials
WO2004023983A2 (en) * 2002-09-13 2004-03-25 The Regents Of The University Of Michigan Noninvasive nonlinear systems and methods for predicting seizure
US6718210B1 (en) 1995-06-07 2004-04-06 Case Western Reserve University Functional neuromuscular stimulation system
US6725086B2 (en) 2001-01-17 2004-04-20 Draeger Medical Systems, Inc. Method and system for monitoring sedation, paralysis and neural-integrity
US20040082875A1 (en) * 2002-10-24 2004-04-29 Brown University Research Foundation Microstructured arrays for cortex interaction and related methods of manufacture and use
WO2004043536A1 (en) 2002-11-12 2004-05-27 Neuropace, Inc. System for adaptive brain stimulation
US20040133120A1 (en) * 2002-10-15 2004-07-08 Medtronic, Inc. Phase shifting of neurological signals in a medical device system
US20040133248A1 (en) * 2002-10-15 2004-07-08 Medtronic, Inc. Channel-selective blanking for a medical device system
US20040138536A1 (en) * 2002-10-15 2004-07-15 Medtronic, Inc. Clustering of recorded patient neurological activity to determine length of a neurological event
US20040138517A1 (en) * 2002-10-15 2004-07-15 Medtronic, Inc. Multi-modal operation of a medical device system
US20040138518A1 (en) * 2002-10-15 2004-07-15 Medtronic, Inc. Medical device system with relaying module for treatment of nervous system disorders
US20040138580A1 (en) * 2002-10-15 2004-07-15 Medtronic, Inc. Signal quality monitoring and control for a medical device system
US20040138647A1 (en) * 2002-10-15 2004-07-15 Medtronic, Inc. Cycle mode providing redundant back-up to ensure termination of treatment therapy in a medical device system
US20040153129A1 (en) * 1997-10-27 2004-08-05 Neuropace, Inc. System and method for controlling neurological disorders with spatially separated detection and therapy locations
US20040153436A1 (en) * 2002-10-15 2004-08-05 Pope Cameron A. Automated information management system and methods
US20040158119A1 (en) * 2002-10-15 2004-08-12 Medtronic, Inc. Screening techniques for management of a nervous system disorder
US20040236387A1 (en) * 1998-06-03 2004-11-25 Neurocontrol Corporation Treatment of shoulder dysfunction using a percutaneous intramuscular stimulation system
US20040249422A1 (en) * 2002-12-10 2004-12-09 Gliner Bradford Evan Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of movement disorders and/or other neurologic dysfunction
US20050049650A1 (en) * 2000-10-30 2005-03-03 Medtronic, Inc. Method for treating obsessive-compulsive disorder with electrical stimulation of the brain internal capsule
US20050113886A1 (en) * 2003-11-24 2005-05-26 Fischell David R. Implantable medical system with long range telemetry
US20050113744A1 (en) * 2003-11-21 2005-05-26 Cyberkinetics, Inc. Agent delivery systems and related methods under control of biological electrical signals
EP1554011A2 (en) * 2002-10-15 2005-07-20 Northstar Neuroscience, Inc. Neural stimulation system and method responsive to collateral neural activity
US20050197590A1 (en) * 1997-01-06 2005-09-08 Ivan Osorio System for the prediction, rapid detection, warning, prevention, or control of changes in activity states in the brain of a subject
US20050203366A1 (en) * 2004-03-12 2005-09-15 Donoghue John P. Neurological event monitoring and therapy systems and related methods
US20050209652A1 (en) * 2001-04-26 2005-09-22 Whitehurst Todd K Methods and systems for electrical and/or drug stimulation as a therapy for erectile dysfunction
US20050267597A1 (en) * 2003-11-25 2005-12-01 Flaherty J Christopher Neural interface system with embedded id
US7003352B1 (en) 2002-05-24 2006-02-21 Advanced Bionics Corporation Treatment of epilepsy by brain stimulation
US20060049957A1 (en) * 2004-08-13 2006-03-09 Surgenor Timothy R Biological interface systems with controlled device selector and related methods
US7013177B1 (en) 2001-07-05 2006-03-14 Advanced Bionics Corporation Treatment of pain by brain stimulation
US20060106430A1 (en) * 2004-11-12 2006-05-18 Brad Fowler Electrode configurations for reducing invasiveness and/or enhancing neural stimulation efficacy, and associated methods
US20060155495A1 (en) * 2002-10-15 2006-07-13 Medtronic, Inc. Synchronization and calibration of clocks for a medical device and calibrated clock
US20060167564A1 (en) * 2005-01-10 2006-07-27 Flaherty J C Limb and digit movement system
US20060167371A1 (en) * 2005-01-10 2006-07-27 Flaherty J Christopher Biological interface system with patient training apparatus
US20060173259A1 (en) * 2004-10-04 2006-08-03 Flaherty J C Biological interface system
US20060189900A1 (en) * 2005-01-18 2006-08-24 Flaherty J C Biological interface system with automated configuration
US20060195157A1 (en) * 2004-10-05 2006-08-31 Dartmouth College Apparatus and method for modulating neurochemical levels in the brain
US20060205993A1 (en) * 2000-08-31 2006-09-14 Fischell David R Low frequency magnetic neurostimulator for the treatment of neurological disorders
US20060212093A1 (en) * 2000-04-05 2006-09-21 Pless Benjamin D Differential neurostimulation therapy driven by physiological therapy
US20060229688A1 (en) * 2005-04-08 2006-10-12 Mcclure Kelly H Controlling stimulation parameters of implanted tissue stimulators
US20060253171A1 (en) * 2004-11-12 2006-11-09 Northstar Neuroscience, Inc. Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of parkinson's disease, other movement disorders, and/or drug side effects
US20070032738A1 (en) * 2005-01-06 2007-02-08 Flaherty J C Adaptive patient training routine for biological interface system
US7209787B2 (en) 1998-08-05 2007-04-24 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20070106143A1 (en) * 2005-11-08 2007-05-10 Flaherty J C Electrode arrays and related methods
US7231254B2 (en) 1998-08-05 2007-06-12 Bioneuronics Corporation Closed-loop feedback-driven neuromodulation
US20070156126A1 (en) * 2005-12-29 2007-07-05 Flaherty J C Medical device insertion system and related methods
US7242984B2 (en) 1998-08-05 2007-07-10 Neurovista Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20070162086A1 (en) * 1998-08-05 2007-07-12 Bioneuronics Corporation Monitoring efficacy of neural modulation therapy
WO2006044793A3 (en) * 2004-10-18 2007-08-23 Univ Louisiana Tech Foundation Medical devices for the detection, prevention and/or treatment of neurological disorders, and methods related thereto
US20070225765A1 (en) * 2006-03-22 2007-09-27 Medtronic, Inc. Technique for adjusting the locus of excitation of electrically excitable tissue with paired pulses
US7277758B2 (en) 1998-08-05 2007-10-02 Neurovista Corporation Methods and systems for predicting future symptomatology in a patient suffering from a neurological or psychiatric disorder
US20070255323A1 (en) * 2006-04-28 2007-11-01 Medtronic, Inc. Implantable medical device for the concurrent treatment of a plurality of neurological disorders and method therefore
US7299096B2 (en) 2001-03-08 2007-11-20 Northstar Neuroscience, Inc. System and method for treating Parkinson's Disease and other movement disorders
US20070287984A1 (en) * 2006-06-09 2007-12-13 Neurosystec Corporation Flow-Induced Delivery from a Drug Mass
US7324851B1 (en) 1998-08-05 2008-01-29 Neurovista Corporation Closed-loop feedback-driven neuromodulation
US20080033508A1 (en) * 2002-10-15 2008-02-07 Medtronic, Inc. Clustering of recorded patient neurological activity to determine length of a neurological event
US20080065002A1 (en) * 2006-09-07 2008-03-13 Neurosystec Corporation Catheter for Localized Drug Delivery and/or Electrical Stimulation
US7392079B2 (en) 2001-11-14 2008-06-24 Brown University Research Foundation Neurological signal decoding
US20080152694A1 (en) * 2006-07-20 2008-06-26 Neurosystec Corporation Devices, Systems and Methods for Ophthalmic Drug Delivery
US7403820B2 (en) 1998-08-05 2008-07-22 Neurovista Corporation Closed-loop feedback-driven neuromodulation
US7483747B2 (en) 2004-07-15 2009-01-27 Northstar Neuroscience, Inc. Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
US7565199B2 (en) 2002-12-09 2009-07-21 Advanced Neuromodulation Systems, Inc. Methods for treating and/or collecting information regarding neurological disorders, including language disorders
US7627383B2 (en) 2005-03-15 2009-12-01 Boston Scientific Neuromodulation Corporation Implantable stimulator
US7647097B2 (en) 2003-12-29 2010-01-12 Braingate Co., Llc Transcutaneous implant
US20100023021A1 (en) * 2005-12-27 2010-01-28 Flaherty J Christopher Biological Interface and Insertion
US20100030299A1 (en) * 2007-04-13 2010-02-04 Alejandro Covalin Apparatus and method for the treatment of headache
US20100036454A1 (en) * 1998-06-03 2010-02-11 Ndi Medical, Llc. Systems and methods to place one or more leads in muscle for providing electrical stimulation to treat pain
US7676263B2 (en) 2006-06-23 2010-03-09 Neurovista Corporation Minimally invasive system for selecting patient-specific therapy parameters
US7684866B2 (en) 2003-08-01 2010-03-23 Advanced Neuromodulation Systems, Inc. Apparatus and methods for applying neural stimulation to a patient
US7715919B2 (en) 2002-10-15 2010-05-11 Medtronic, Inc. Control of treatment therapy during start-up and during operation of a medical device system
US7729758B2 (en) 2005-11-30 2010-06-01 Boston Scientific Neuromodulation Corporation Magnetically coupled microstimulators
US7747325B2 (en) 1998-08-05 2010-06-29 Neurovista Corporation Systems and methods for monitoring a patient's neurological disease state
US7756584B2 (en) 2000-07-13 2010-07-13 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US7801600B1 (en) 2005-05-26 2010-09-21 Boston Scientific Neuromodulation Corporation Controlling charge flow in the electrical stimulation of tissue
US20100312305A1 (en) * 2004-10-05 2010-12-09 The Trustees Of Dartmouth College Apparatus And Method For Modulating Neurochemical Levels In the Brain
US7865243B1 (en) 2000-04-07 2011-01-04 Boston Scientific Neuromodulation Corporation Device and therapy for erectile dysfunction and other sexual dysfunction
US7877136B1 (en) 2007-09-28 2011-01-25 Boston Scientific Neuromodulation Corporation Enhancement of neural signal transmission through damaged neural tissue via hyperpolarizing electrical stimulation current
US7901368B2 (en) 2005-01-06 2011-03-08 Braingate Co., Llc Neurally controlled patient ambulation system
US20110077579A1 (en) * 2005-03-24 2011-03-31 Harrison William V Cochlear implant with localized fluid transport
US7970722B1 (en) 1999-11-08 2011-06-28 Aloft Media, Llc System, method and computer program product for a collaborative decision platform
US7974696B1 (en) 1998-08-05 2011-07-05 Dilorenzo Biomedical, Llc Closed-loop autonomic neuromodulation for optimal control of neurological and metabolic disease
US20110213222A1 (en) * 2007-01-25 2011-09-01 Leyde Kent W Communication Error Alerting in an Epilepsy Monitoring System
US8036736B2 (en) 2007-03-21 2011-10-11 Neuro Vista Corporation Implantable systems and methods for identifying a contra-ictal condition in a subject
US8065012B2 (en) 2000-07-13 2011-11-22 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US8095209B2 (en) 2005-01-06 2012-01-10 Braingate Co., Llc Biological interface system with gated control signal
US8187181B2 (en) 2002-10-15 2012-05-29 Medtronic, Inc. Scoring of sensed neurological signals for use with a medical device system
US8295934B2 (en) 2006-11-14 2012-10-23 Neurovista Corporation Systems and methods of reducing artifact in neurological stimulation systems
US20130090706A1 (en) * 2011-10-05 2013-04-11 Randolph J. Nudo Methods and associated neural prosthetic devices for bridging brain areas to improve function
US8543214B2 (en) 2002-10-15 2013-09-24 Medtronic, Inc. Configuring and testing treatment therapy parameters for a medical device system
US8588933B2 (en) 2009-01-09 2013-11-19 Cyberonics, Inc. Medical lead termination sleeve for implantable medical devices
US8725243B2 (en) 2005-12-28 2014-05-13 Cyberonics, Inc. Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US8762065B2 (en) 1998-08-05 2014-06-24 Cyberonics, Inc. Closed-loop feedback-driven neuromodulation
US8786624B2 (en) 2009-06-02 2014-07-22 Cyberonics, Inc. Processing for multi-channel signals
CN103932703A (en) * 2014-05-09 2014-07-23 云南大学 Method for recording sleep electrophysiological signals of primates
US8849390B2 (en) 2008-12-29 2014-09-30 Cyberonics, Inc. Processing for multi-channel signals
US8868172B2 (en) 2005-12-28 2014-10-21 Cyberonics, Inc. Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
US8929991B2 (en) 2005-10-19 2015-01-06 Advanced Neuromodulation Systems, Inc. Methods for establishing parameters for neural stimulation, including via performance of working memory tasks, and associated kits
US9042988B2 (en) 1998-08-05 2015-05-26 Cyberonics, Inc. Closed-loop vagus nerve stimulation
US9050469B1 (en) * 2003-11-26 2015-06-09 Flint Hills Scientific, Llc Method and system for logging quantitative seizure information and assessing efficacy of therapy using cardiac signals
US9259591B2 (en) 2007-12-28 2016-02-16 Cyberonics, Inc. Housing for an implantable medical device
CN105640549A (en) * 2016-03-18 2016-06-08 杭州妞诺科技有限公司 Electroencephalography epilepsy signal record analyzer and detection method thereof
US9375573B2 (en) 1998-08-05 2016-06-28 Cyberonics, Inc. Systems and methods for monitoring a patient's neurological disease state
US9415222B2 (en) 1998-08-05 2016-08-16 Cyberonics, Inc. Monitoring an epilepsy disease state with a supervisory module
US9643019B2 (en) 2010-02-12 2017-05-09 Cyberonics, Inc. Neurological monitoring and alerts
US9788744B2 (en) 2007-07-27 2017-10-17 Cyberonics, Inc. Systems for monitoring brain activity and patient advisory device
US9898656B2 (en) 2007-01-25 2018-02-20 Cyberonics, Inc. Systems and methods for identifying a contra-ictal condition in a subject
US10076663B2 (en) 2010-11-11 2018-09-18 Spr Therapeutics, Inc. Systems and methods for the treatment of pain through neural fiber stimulation
US10722715B2 (en) 2010-11-11 2020-07-28 Spr Therapeutics, Inc. Systems and methods for the treatment of pain through neural fiber stimulation
US10857361B2 (en) 2010-11-11 2020-12-08 Spr Therapeutics, Inc. Systems and methods for the treatment of pain through neural fiber stimulation
US10888701B2 (en) 2007-11-14 2021-01-12 Pacesetter, Inc. Implantable cardiac stimulation device and method that stabilizes ventricular rate during episodes of atrial fibrillation
US11406317B2 (en) 2007-12-28 2022-08-09 Livanova Usa, Inc. Method for detecting neurological and clinical manifestations of a seizure
US11540973B2 (en) 2016-10-21 2023-01-03 Spr Therapeutics, Llc Method and system of mechanical nerve stimulation for pain relief

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3032029A (en) * 1958-07-09 1962-05-01 Thompson Ramo Wooldridge Inc System controlling apparatus and method
US3495596A (en) * 1964-08-26 1970-02-17 Medel Corp Apparatus for and method of processing a bioelectrical signal
US3510765A (en) * 1967-07-31 1970-05-05 Humetrics Corp Method and apparatus for gating variably recurrent waveforms
US3513834A (en) * 1966-11-21 1970-05-26 Hitachi Ltd Anesthetic depth measuring system
US3587563A (en) * 1969-01-08 1971-06-28 Us Army Heartbeat monitor
US3699970A (en) * 1969-06-26 1972-10-24 Nat Res Dev Striate cortex stimulator

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3032029A (en) * 1958-07-09 1962-05-01 Thompson Ramo Wooldridge Inc System controlling apparatus and method
US3495596A (en) * 1964-08-26 1970-02-17 Medel Corp Apparatus for and method of processing a bioelectrical signal
US3513834A (en) * 1966-11-21 1970-05-26 Hitachi Ltd Anesthetic depth measuring system
US3510765A (en) * 1967-07-31 1970-05-05 Humetrics Corp Method and apparatus for gating variably recurrent waveforms
US3587563A (en) * 1969-01-08 1971-06-28 Us Army Heartbeat monitor
US3699970A (en) * 1969-06-26 1972-10-24 Nat Res Dev Striate cortex stimulator

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
John Osmundson, Matador with Radio Stops Wired Bull New York Times Newspaper, pg. 1 & 20, 5 17 65. *

Cited By (325)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888260A (en) * 1972-06-28 1975-06-10 Univ Johns Hopkins Rechargeable demand inhibited cardiac pacer and tissue stimulator
US3993046A (en) * 1974-11-06 1976-11-23 Heriberto Fernandez Seizure suppression device
US4165750A (en) * 1978-03-18 1979-08-28 Aleev Leonid S Bioelectrically controlled electric stimulator of human muscles
US4230125A (en) * 1979-07-09 1980-10-28 Schneider Daniel E Method and apparatus for effecting the prospective forewarning diagnosis of sudden brain death and heart death and other brain-heart-body growth maladies such as schizophrenia and cancer and the like
US4440160A (en) * 1982-01-19 1984-04-03 The Johns Hopkins University Self-injurious behavior inhibiting system
US4524773A (en) * 1983-08-24 1985-06-25 The John Hopkins University Apparatus for inhibiting self-injurious behavior (SIB) in patients
WO1985001213A1 (en) * 1983-09-14 1985-03-28 Jacob Zabara Neurocybernetic prosthesis
AU577549B2 (en) * 1983-09-14 1988-09-29 Jacob Zabara Neurocybernetic prothesis
JPH0449423B2 (en) * 1983-09-14 1992-08-11 Jakobu Zabara
JPS60502192A (en) * 1983-09-14 1985-12-19 ザバラ,ジヤコブ neurocybernetic prosthetics
US5025807A (en) * 1983-09-14 1991-06-25 Jacob Zabara Neurocybernetic prosthesis
US4702254A (en) * 1983-09-14 1987-10-27 Jacob Zabara Neurocybernetic prosthesis
US4867164A (en) * 1983-09-14 1989-09-19 Jacob Zabara Neurocybernetic prosthesis
US4554928A (en) * 1983-09-16 1985-11-26 Webster Wilton W Jr Electrophysiological switching unit
WO1985001214A1 (en) * 1983-09-16 1985-03-28 Webster Wilton W Jr Electrophysiological switching unit
US5443710A (en) * 1984-05-09 1995-08-22 Research Foundation, The City University Of New York Microelectrodes and their use in a cathodic electrochemical current arrangement with telemetric application
US4883057A (en) * 1984-05-09 1989-11-28 Research Foundation, The City University Of New York Cathodic electrochemical current arrangement with telemetric application
WO1986002567A1 (en) * 1984-10-23 1986-05-09 Zion Foundation Method and apparatus for delivering a prescriptive electrical signal
US4709700A (en) * 1985-03-11 1987-12-01 Vaclav Hyrman Electro convulsive therapy method
US6026328A (en) * 1986-03-24 2000-02-15 Case Western Reserve University Functional neuromuscular stimulation system with shielded percutaneous interface
US5167229A (en) * 1986-03-24 1992-12-01 Case Western Reserve University Functional neuromuscular stimulation system
US5299569A (en) * 1991-05-03 1994-04-05 Cyberonics, Inc. Treatment of neuropsychiatric disorders by nerve stimulation
US5522863A (en) * 1992-08-19 1996-06-04 The United States Of America As Represented By The Secretary Of The Navy Pulsating behavior monitoring and modification system for neural networks
US5311876A (en) * 1992-11-18 1994-05-17 The Johns Hopkins University Automatic detection of seizures using electroencephalographic signals
WO1995015117A1 (en) * 1993-11-30 1995-06-08 University Of Washington Method and apparatus for detecting epileptic seizures
US5349962A (en) * 1993-11-30 1994-09-27 University Of Washington Method and apparatus for detecting epileptic seizures
US5743854A (en) * 1994-03-29 1998-04-28 The Regents Of The University Of California Method and apparatus for inducing and localizing epileptiform activity
US5797965A (en) * 1994-08-19 1998-08-25 The United States Of America As Represented By The Secretary Of The Navy Suppression of epileptiform activity
US6163725A (en) * 1994-09-06 2000-12-19 Case Western Reserve University Functional neuromuscular stimulation system
US5954758A (en) * 1994-09-06 1999-09-21 Case Western Reserve University Functional neuromuscular stimulation system
US5559498A (en) * 1994-12-30 1996-09-24 Innotek Inc. Combination confinement and remote training system
US5609617A (en) * 1995-02-21 1997-03-11 C. Norman Shealy Method for enhancement of dehydroepiandrosterone
US6718210B1 (en) 1995-06-07 2004-04-06 Case Western Reserve University Functional neuromuscular stimulation system
US5700282A (en) * 1995-10-13 1997-12-23 Zabara; Jacob Heart rhythm stabilization using a neurocybernetic prosthesis
US6549804B1 (en) 1996-01-23 2003-04-15 University Of Kansas System for the prediction, rapid detection, warning, prevention or control of changes in activity states in the brain of a subject
US5995868A (en) * 1996-01-23 1999-11-30 University Of Kansas System for the prediction, rapid detection, warning, prevention, or control of changes in activity states in the brain of a subject
US6463328B1 (en) * 1996-02-02 2002-10-08 Michael Sasha John Adaptive brain stimulation method and system
US6066163A (en) * 1996-02-02 2000-05-23 John; Michael Sasha Adaptive brain stimulation method and system
US5916239A (en) * 1996-03-29 1999-06-29 Purdue Research Foundation Method and apparatus using vagal stimulation for control of ventricular rate during atrial fibrillation
US5690681A (en) * 1996-03-29 1997-11-25 Purdue Research Foundation Method and apparatus using vagal stimulation for control of ventricular rate during atrial fibrillation
US20030018370A1 (en) * 1996-04-04 2003-01-23 Medtronic, Inc. Technique for adjusting the locus of excitation of electrically excitable tissue
US5814092A (en) * 1996-04-04 1998-09-29 Medtronic Inc. Neural stimulation techniques with feedback
US5913882A (en) * 1996-04-04 1999-06-22 Medtronic Inc. Neural stimulation techniques with feedback
US20100137926A1 (en) * 1996-04-04 2010-06-03 Medtronic, Inc. Technique for Adjusting the Locus of Excitation of Electrically Excitable Tissue
US20060079937A1 (en) * 1996-04-04 2006-04-13 Medtronic, Inc. Technique for adjusting the locus of excitation of electrically excitable tissue
US7657318B2 (en) 1996-04-04 2010-02-02 Medtronic, Inc. Technique for adjusting the locus of excitation of electrically excitable tissue
US6988006B2 (en) 1996-04-04 2006-01-17 Medtronic, Inc. Technique for adjusting the locus of excitation of electrically excitable tissue
US5716377A (en) * 1996-04-25 1998-02-10 Medtronic, Inc. Method of treating movement disorders by brain stimulation
US5713922A (en) * 1996-04-25 1998-02-03 Medtronic, Inc. Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain
US5683422A (en) * 1996-04-25 1997-11-04 Medtronic, Inc. Method and apparatus for treating neurodegenerative disorders by electrical brain stimulation
US5833709A (en) * 1996-04-25 1998-11-10 Medtronic, Inc. Method of treating movement disorders by brain stimulation
US5707396A (en) * 1996-04-25 1998-01-13 Institute National De La Sante De La Recherche Medicale (Inserm) Method of arresting degeneration of the substantia nigra by high frequency stimulation of subthalamic nucleus
US5792186A (en) * 1996-04-25 1998-08-11 Medtronic, Inc. Method and apparatus for treating neurodegenerative disorders by electrical brain stimulation
US5713923A (en) * 1996-05-13 1998-02-03 Medtronic, Inc. Techniques for treating epilepsy by brain stimulation and drug infusion
US5752979A (en) * 1996-11-01 1998-05-19 Medtronic, Inc. Method of controlling epilepsy by brain stimulation
US5800474A (en) * 1996-11-01 1998-09-01 Medtronic, Inc. Method of controlling epilepsy by brain stimulation
US20050197590A1 (en) * 1997-01-06 2005-09-08 Ivan Osorio System for the prediction, rapid detection, warning, prevention, or control of changes in activity states in the brain of a subject
US7630757B2 (en) 1997-01-06 2009-12-08 Flint Hills Scientific Llc System for the prediction, rapid detection, warning, prevention, or control of changes in activity states in the brain of a subject
US6128537A (en) * 1997-05-01 2000-10-03 Medtronic, Inc Techniques for treating anxiety by brain stimulation and drug infusion
US6263237B1 (en) 1997-05-01 2001-07-17 Medtronic, Inc. Techniques for treating anxiety disorders by brain stimulation and drug infusion
US5975085A (en) * 1997-05-01 1999-11-02 Medtronic, Inc. Method of treating schizophrenia by brain stimulation and drug infusion
US6023642A (en) * 1997-05-08 2000-02-08 Biogenics Ii, Llc Compact transcutaneous electrical nerve stimulator
US20040153129A1 (en) * 1997-10-27 2004-08-05 Neuropace, Inc. System and method for controlling neurological disorders with spatially separated detection and therapy locations
US6354299B1 (en) 1997-10-27 2002-03-12 Neuropace, Inc. Implantable device for patient communication
US20010051819A1 (en) * 1997-10-27 2001-12-13 Fischell Robert E. Implantable apparatus for treating neurological disorders
US6647296B2 (en) * 1997-10-27 2003-11-11 Neuropace, Inc. Implantable apparatus for treating neurological disorders
US6459936B2 (en) * 1997-10-27 2002-10-01 Neuropace, Inc. Methods for responsively treating neurological disorders
EP0911061A3 (en) * 1997-10-27 1999-11-24 Neuropace, Inc. System for the treatment of neurological disorders
US20060224216A1 (en) * 1997-10-27 2006-10-05 Pless Benjamin D System and method for controlling neurological disorders with spatially separated detection and therapy locations
EP0911061A2 (en) 1997-10-27 1999-04-28 Neuropace, Inc. System for the treatment of neurological disorders
US6227203B1 (en) 1998-02-12 2001-05-08 Medtronic, Inc. Techniques for controlling abnormal involuntary movements by brain stimulation and drug infusion
US6374140B1 (en) * 1998-04-30 2002-04-16 Medtronic, Inc. Method and apparatus for treating seizure disorders by stimulating the olfactory senses
US6018682A (en) * 1998-04-30 2000-01-25 Medtronic, Inc. Implantable seizure warning system
US5938689A (en) * 1998-05-01 1999-08-17 Neuropace, Inc. Electrode configuration for a brain neuropacemaker
US6006124A (en) * 1998-05-01 1999-12-21 Neuropace, Inc. Means and method for the placement of brain electrodes
US8249713B2 (en) 1998-06-03 2012-08-21 Spr Therapeutics, Llc Treatment of shoulder dysfunction using a percutaneous intramuscular stimulation system
US6845271B2 (en) 1998-06-03 2005-01-18 Neurocontrol Corporation Treatment of shoulder dysfunction using a percutaneous intramuscular stimulation system
US20080065171A1 (en) * 1998-06-03 2008-03-13 Neurocontrol Corporation Treatment of shoulder dysfunction using a percutaneous intramuscular stimulation system
US8626302B2 (en) 1998-06-03 2014-01-07 Spr Therapeutics, Llc Systems and methods to place one or more leads in muscle for providing electrical stimulation to treat pain
US20040236387A1 (en) * 1998-06-03 2004-11-25 Neurocontrol Corporation Treatment of shoulder dysfunction using a percutaneous intramuscular stimulation system
US20100036454A1 (en) * 1998-06-03 2010-02-11 Ndi Medical, Llc. Systems and methods to place one or more leads in muscle for providing electrical stimulation to treat pain
US9375573B2 (en) 1998-08-05 2016-06-28 Cyberonics, Inc. Systems and methods for monitoring a patient's neurological disease state
US9113801B2 (en) 1998-08-05 2015-08-25 Cyberonics, Inc. Methods and systems for continuous EEG monitoring
US7209787B2 (en) 1998-08-05 2007-04-24 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US7324851B1 (en) 1998-08-05 2008-01-29 Neurovista Corporation Closed-loop feedback-driven neuromodulation
US7623928B2 (en) 1998-08-05 2009-11-24 Neurovista Corporation Controlling a subject's susceptibility to a seizure
US7403820B2 (en) 1998-08-05 2008-07-22 Neurovista Corporation Closed-loop feedback-driven neuromodulation
US7242984B2 (en) 1998-08-05 2007-07-10 Neurovista Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US6366813B1 (en) 1998-08-05 2002-04-02 Dilorenzo Daniel J. Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease
US7853329B2 (en) 1998-08-05 2010-12-14 Neurovista Corporation Monitoring efficacy of neural modulation therapy
US9421373B2 (en) 1998-08-05 2016-08-23 Cyberonics, Inc. Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US9415222B2 (en) 1998-08-05 2016-08-16 Cyberonics, Inc. Monitoring an epilepsy disease state with a supervisory module
US20070162086A1 (en) * 1998-08-05 2007-07-12 Bioneuronics Corporation Monitoring efficacy of neural modulation therapy
US7747325B2 (en) 1998-08-05 2010-06-29 Neurovista Corporation Systems and methods for monitoring a patient's neurological disease state
US9345880B1 (en) 1998-08-05 2016-05-24 Daniel John DiLorenzo Closed-loop feedback-driven sympathetic neuromodulation for affect control
US9320900B2 (en) 1998-08-05 2016-04-26 Cyberonics, Inc. Methods and systems for determining subject-specific parameters for a neuromodulation therapy
US7974696B1 (en) 1998-08-05 2011-07-05 Dilorenzo Biomedical, Llc Closed-loop autonomic neuromodulation for optimal control of neurological and metabolic disease
US9042988B2 (en) 1998-08-05 2015-05-26 Cyberonics, Inc. Closed-loop vagus nerve stimulation
US7277758B2 (en) 1998-08-05 2007-10-02 Neurovista Corporation Methods and systems for predicting future symptomatology in a patient suffering from a neurological or psychiatric disorder
US7231254B2 (en) 1998-08-05 2007-06-12 Bioneuronics Corporation Closed-loop feedback-driven neuromodulation
US7930035B2 (en) 1998-08-05 2011-04-19 Neurovista Corporation Providing output indicative of subject's disease state
US8781597B2 (en) 1998-08-05 2014-07-15 Cyberonics, Inc. Systems for monitoring a patient's neurological disease state
US8762065B2 (en) 1998-08-05 2014-06-24 Cyberonics, Inc. Closed-loop feedback-driven neuromodulation
US6819956B2 (en) 1998-08-05 2004-11-16 Dilorenzo Daniel J. Optimal method and apparatus for neural modulation for the treatment of neurological disease, particularly movement disorders
US6658287B1 (en) 1998-08-24 2003-12-02 Georgia Tech Research Corporation Method and apparatus for predicting the onset of seizures based on features derived from signals indicative of brain activity
US6161044A (en) * 1998-11-23 2000-12-12 Synaptic Corporation Method and apparatus for treating chronic pain syndromes, tremor, dementia and related disorders and for inducing electroanesthesia using high frequency, high intensity transcutaneous electrical nerve stimulation
US6161045A (en) * 1999-06-01 2000-12-12 Neuropace, Inc. Method for determining stimulation parameters for the treatment of epileptic seizures
US6230049B1 (en) * 1999-08-13 2001-05-08 Neuro Pace, Inc. Integrated system for EEG monitoring and electrical stimulation with a multiplicity of electrodes
US6304775B1 (en) 1999-09-22 2001-10-16 Leonidas D. Iasemidis Seizure warning and prediction
US7970722B1 (en) 1999-11-08 2011-06-28 Aloft Media, Llc System, method and computer program product for a collaborative decision platform
US8160988B1 (en) 1999-11-08 2012-04-17 Aloft Media, Llc System, method and computer program product for a collaborative decision platform
US8005777B1 (en) 1999-11-08 2011-08-23 Aloft Media, Llc System, method and computer program product for a collaborative decision platform
US20040073273A1 (en) * 1999-12-07 2004-04-15 Gluckman Bruce J. Adaptive electric field modulation of neural systems
US6873872B2 (en) 1999-12-07 2005-03-29 George Mason University Adaptive electric field modulation of neural systems
US20030114886A1 (en) * 1999-12-07 2003-06-19 Gluckman Bruce J. Adaptive electric field modulation of neural systems
US6665562B2 (en) 1999-12-07 2003-12-16 George Mason University Adaptive electric field modulation of neural systems
US9878160B2 (en) 2000-04-05 2018-01-30 Neuropace, Inc. Differential neurostimulation therapy driven by physiological therapy
US9943690B2 (en) 2000-04-05 2018-04-17 Neuropace, Inc. Differential neurostimulation therapy driven by physiological therapy
US20060212093A1 (en) * 2000-04-05 2006-09-21 Pless Benjamin D Differential neurostimulation therapy driven by physiological therapy
US7966073B2 (en) * 2000-04-05 2011-06-21 Neuropace, Inc. Differential neurostimulation therapy driven by physiological therapy
US9451891B2 (en) 2000-04-05 2016-09-27 Neuropace Inc. Differential neurostimulation therapy driven by physiological therapy
US8423145B2 (en) 2000-04-05 2013-04-16 Neuropace, Inc. Differential neurostimulation therapy driven by physiological therapy
US8934980B2 (en) 2000-04-05 2015-01-13 Neuropace, Inc. Differential neurostimulation therapy driven by physiological therapy
US8224452B2 (en) 2000-04-05 2012-07-17 Neuropace Inc. Differential neurostimulation therapy driven by physiological therapy
US20110218591A1 (en) * 2000-04-05 2011-09-08 Neuropace, Inc. Differential Neurostimulation Therapy Driven By Physiological Therapy
US7890177B1 (en) 2000-04-07 2011-02-15 Boston Scientific Neuromodulation Corporation Device and therapy for erectile dysfunction and other sexual dysfunction
US7865243B1 (en) 2000-04-07 2011-01-04 Boston Scientific Neuromodulation Corporation Device and therapy for erectile dysfunction and other sexual dysfunction
US8065012B2 (en) 2000-07-13 2011-11-22 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US8073546B2 (en) 2000-07-13 2011-12-06 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US7756584B2 (en) 2000-07-13 2010-07-13 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US10279191B2 (en) 2000-08-31 2019-05-07 Neuropace, Inc. Low frequency neurostimulator for the treatment of neurological disorders
US9033861B2 (en) 2000-08-31 2015-05-19 Neuropace, Inc. Low frequency neurostimulator for the treatment of neurological disorders
US9694195B2 (en) 2000-08-31 2017-07-04 Neuropace, Inc. Low frequency neurostimulator for the treatment of neurological disorders
US20090318747A1 (en) * 2000-08-31 2009-12-24 Neuropace, Inc. Low Frequency Neurostimulator for the Treatment of Neurological Disorders
US9352168B2 (en) 2000-08-31 2016-05-31 Neuropace, Inc. Low frequency neurostimulator for the treatment of neurological disorders
US7601116B2 (en) 2000-08-31 2009-10-13 Neuropace, Inc. Low frequency magnetic neurostimulator for the treatment of neurological disorders
US20060205993A1 (en) * 2000-08-31 2006-09-14 Fischell David R Low frequency magnetic neurostimulator for the treatment of neurological disorders
US8086294B2 (en) 2000-10-20 2011-12-27 The Trustees Of The University Of Pennsylvania Unified probabilistic framework for predicting and detecting seizure onsets in the brain and multitherapeutic device
US7333851B2 (en) 2000-10-20 2008-02-19 The Trustees Of The University Of Pennsylvania Unified probabilistic framework for predicting and detecting seizure onsets in the brain and multitherapeutic device
US6678548B1 (en) 2000-10-20 2004-01-13 The Trustees Of The University Of Pennsylvania Unified probabilistic framework for predicting and detecting seizure onsets in the brain and multitherapeutic device
US20050049650A1 (en) * 2000-10-30 2005-03-03 Medtronic, Inc. Method for treating obsessive-compulsive disorder with electrical stimulation of the brain internal capsule
WO2002038031A3 (en) * 2000-10-30 2003-10-23 Neuropace Inc System and method for determining stimulation parameters for the treatment of epileptic seizures
WO2002038031A2 (en) * 2000-10-30 2002-05-16 Neuropace, Inc. System and method for determining stimulation parameters for the treatment of epileptic seizures
US7616998B2 (en) 2000-10-30 2009-11-10 Medtronic, Inc. Electrical stimulation of structures within the brain
US20030158587A1 (en) * 2000-12-12 2003-08-21 The Trustees Of The University Of Pennsylvania Adaptive method and apparatus for forecasting and controlling neurological disturbances under a multi-level control
US20070142873A1 (en) * 2000-12-12 2007-06-21 Rosana Esteller Adaptive Method and Apparatus for Forecasting and Controlling Neurological Disturbances under a multi-level control
US7146218B2 (en) 2000-12-12 2006-12-05 The Trustees Of The University Of Pennsylvania Adaptive method and apparatus for forecasting and controlling neurological disturbances under a multi-level control
US6594524B2 (en) 2000-12-12 2003-07-15 The Trustees Of The University Of Pennsylvania Adaptive method and apparatus for forecasting and controlling neurological disturbances under a multi-level control
US8065011B2 (en) 2000-12-12 2011-11-22 The Trustees Of The University Of Pennsylvania Adaptive method and apparatus for forecasting and controlling neurological disturbances under a multi-level control
US6725086B2 (en) 2001-01-17 2004-04-20 Draeger Medical Systems, Inc. Method and system for monitoring sedation, paralysis and neural-integrity
US7299096B2 (en) 2001-03-08 2007-11-20 Northstar Neuroscience, Inc. System and method for treating Parkinson's Disease and other movement disorders
US7660631B2 (en) 2001-04-26 2010-02-09 Boston Scientific Neuromodulation Corporation Methods and systems for electrical and/or drug stimulation as a therapy for erectile dysfunction
US20050209652A1 (en) * 2001-04-26 2005-09-22 Whitehurst Todd K Methods and systems for electrical and/or drug stimulation as a therapy for erectile dysfunction
US8467879B1 (en) 2001-07-05 2013-06-18 Boston Scientific Neuromodulation Corporation Treatment of pain by brain stimulation
US7013177B1 (en) 2001-07-05 2006-03-14 Advanced Bionics Corporation Treatment of pain by brain stimulation
US6606521B2 (en) 2001-07-09 2003-08-12 Neuropace, Inc. Implantable medical lead
US7831305B2 (en) 2001-10-15 2010-11-09 Advanced Neuromodulation Systems, Inc. Neural stimulation system and method responsive to collateral neural activity
US7392079B2 (en) 2001-11-14 2008-06-24 Brown University Research Foundation Neurological signal decoding
US7003352B1 (en) 2002-05-24 2006-02-21 Advanced Bionics Corporation Treatment of epilepsy by brain stimulation
US20040015211A1 (en) * 2002-06-04 2004-01-22 Nurmikko Arto V. Optically-connected implants and related systems and methods of use
US7280870B2 (en) 2002-06-04 2007-10-09 Brown University Research Foundation Optically-connected implants and related systems and methods of use
US20030236558A1 (en) * 2002-06-20 2003-12-25 Whitehurst Todd K. Vagus nerve stimulation via unidirectional propagation of action potentials
US20040015204A1 (en) * 2002-06-20 2004-01-22 Whitehurst Todd K. Implantable microstimulators and methods for unidirectional propagation of action potentials
US7899539B2 (en) 2002-06-20 2011-03-01 Boston Scientific Neuromodulation Corporation Cavernous nerve stimulation via unidirectional propagation of action potentials
US8548604B2 (en) 2002-06-20 2013-10-01 Boston Scientific Neuromodulation Corporation Implantable microstimulators and methods for unidirectional propagation of action potentials
US7860570B2 (en) 2002-06-20 2010-12-28 Boston Scientific Neuromodulation Corporation Implantable microstimulators and methods for unidirectional propagation of action potentials
US8712547B2 (en) 2002-06-20 2014-04-29 Boston Scientific Neuromodulation Corporation Cavernous nerve stimulation via unidirectional propagation of action potentials
US7292890B2 (en) * 2002-06-20 2007-11-06 Advanced Bionics Corporation Vagus nerve stimulation via unidirectional propagation of action potentials
US7783362B2 (en) 2002-06-20 2010-08-24 Boston Scientific Neuromodulation Corporation Vagus nerve stimulation via unidirectional propagation of action potentials
US20030236557A1 (en) * 2002-06-20 2003-12-25 Whitehurst Todd K. Cavernous nerve stimulation via unidirectional propagation of action potentials
US7203548B2 (en) 2002-06-20 2007-04-10 Advanced Bionics Corporation Cavernous nerve stimulation via unidirectional propagation of action potentials
US9283394B2 (en) 2002-06-20 2016-03-15 Boston Scientific Neuromodulation Corporation Implantable microstimulators and methods for unidirectional propagation of action potentials
US20070021800A1 (en) * 2002-06-20 2007-01-25 Advanced Bionics Corporation, A California Corporation Cavernous nerve stimulation via unidirectional propagation of action potentials
US20040015205A1 (en) * 2002-06-20 2004-01-22 Whitehurst Todd K. Implantable microstimulators with programmable multielectrode configuration and uses thereof
US9409028B2 (en) 2002-06-20 2016-08-09 Boston Scientific Neuromodulation Corporation Implantable microstimulators with programmable multielectrode configuration and uses thereof
WO2004023983A2 (en) * 2002-09-13 2004-03-25 The Regents Of The University Of Michigan Noninvasive nonlinear systems and methods for predicting seizure
WO2004023983A3 (en) * 2002-09-13 2004-06-24 Univ Michigan Noninvasive nonlinear systems and methods for predicting seizure
US20060200038A1 (en) * 2002-09-13 2006-09-07 Robert Savit Noninvasive nonlinear systems and methods for predicting seizure
US8594798B2 (en) 2002-10-15 2013-11-26 Medtronic, Inc. Multi-modal operation of a medical device system
US20040138647A1 (en) * 2002-10-15 2004-07-15 Medtronic, Inc. Cycle mode providing redundant back-up to ensure termination of treatment therapy in a medical device system
US7079977B2 (en) 2002-10-15 2006-07-18 Medtronic, Inc. Synchronization and calibration of clocks for a medical device and calibrated clock
US7976465B2 (en) 2002-10-15 2011-07-12 Medtronic, Inc Phase shifting of neurological signals in a medical device system
US20060161384A1 (en) * 2002-10-15 2006-07-20 Medtronic, Inc. Synchronization and calibration of clocks for a medical device and calibrated clock
US20070100278A1 (en) * 2002-10-15 2007-05-03 Medtronic, Inc. Signal Quality Monitoring And Control For A Medical Device System
US8187181B2 (en) 2002-10-15 2012-05-29 Medtronic, Inc. Scoring of sensed neurological signals for use with a medical device system
US7933646B2 (en) 2002-10-15 2011-04-26 Medtronic, Inc. Clustering of recorded patient neurological activity to determine length of a neurological event
EP1554011A4 (en) * 2002-10-15 2008-06-04 Northstar Neuroscience Inc Neural stimulation system and method responsive to collateral neural activity
US7624293B2 (en) 2002-10-15 2009-11-24 Medtronic, Inc. Synchronization and calibration of clocks for a medical device and calibrated clock
US20070066915A1 (en) * 2002-10-15 2007-03-22 Medtronic, Inc. Phase Shifting of Neurological Signals in a Medical Device System
EP1554011A2 (en) * 2002-10-15 2005-07-20 Northstar Neuroscience, Inc. Neural stimulation system and method responsive to collateral neural activity
US20040133120A1 (en) * 2002-10-15 2004-07-08 Medtronic, Inc. Phase shifting of neurological signals in a medical device system
US20080033508A1 (en) * 2002-10-15 2008-02-07 Medtronic, Inc. Clustering of recorded patient neurological activity to determine length of a neurological event
US7917206B2 (en) 2002-10-15 2011-03-29 Medtronic, Inc. Signal quality monitoring and control for a medical device system
US20040133248A1 (en) * 2002-10-15 2004-07-08 Medtronic, Inc. Channel-selective blanking for a medical device system
US7149572B2 (en) 2002-10-15 2006-12-12 Medtronic, Inc. Phase shifting of neurological signals in a medical device system
US20040138536A1 (en) * 2002-10-15 2004-07-15 Medtronic, Inc. Clustering of recorded patient neurological activity to determine length of a neurological event
US7146211B2 (en) 2002-10-15 2006-12-05 Medtronic, Inc. Signal quality monitoring and control for a medical device system
US20040138517A1 (en) * 2002-10-15 2004-07-15 Medtronic, Inc. Multi-modal operation of a medical device system
US7242983B2 (en) 2002-10-15 2007-07-10 Medtronic, Inc. Channel-selective blanking for a medical device system
US7280867B2 (en) 2002-10-15 2007-10-09 Medtronic, Inc. Clustering of recorded patient neurological activity to determine length of a neurological event
US20040138518A1 (en) * 2002-10-15 2004-07-15 Medtronic, Inc. Medical device system with relaying module for treatment of nervous system disorders
US7715919B2 (en) 2002-10-15 2010-05-11 Medtronic, Inc. Control of treatment therapy during start-up and during operation of a medical device system
US9072832B2 (en) 2002-10-15 2015-07-07 Medtronic, Inc. Clustering of recorded patient neurological activity to determine length of a neurological event
US8543214B2 (en) 2002-10-15 2013-09-24 Medtronic, Inc. Configuring and testing treatment therapy parameters for a medical device system
US7321837B2 (en) 2002-10-15 2008-01-22 Medtronic, Inc. Synchronization and calibration of clocks for a medical device and calibrated clock
US8579786B2 (en) 2002-10-15 2013-11-12 Medtronic, Inc. Screening techniques for management of a nervous system disorder
US20040138580A1 (en) * 2002-10-15 2004-07-15 Medtronic, Inc. Signal quality monitoring and control for a medical device system
US20060155495A1 (en) * 2002-10-15 2006-07-13 Medtronic, Inc. Synchronization and calibration of clocks for a medical device and calibrated clock
US7282030B2 (en) 2002-10-15 2007-10-16 Medtronic, Inc. Timed delay for redelivery of treatment therapy for a medical device system
US20040152958A1 (en) * 2002-10-15 2004-08-05 Medtronic, Inc. Timed delay for redelivery of treatment therapy for a medical device system
US20040153436A1 (en) * 2002-10-15 2004-08-05 Pope Cameron A. Automated information management system and methods
US20040158119A1 (en) * 2002-10-15 2004-08-12 Medtronic, Inc. Screening techniques for management of a nervous system disorder
US8738136B2 (en) 2002-10-15 2014-05-27 Medtronic, Inc. Clustering of recorded patient neurological activity to determine length of a neurological event
US20040082875A1 (en) * 2002-10-24 2004-04-29 Brown University Research Foundation Microstructured arrays for cortex interaction and related methods of manufacture and use
US20070169333A1 (en) * 2002-10-24 2007-07-26 Donoghue John P Microstructured arrays for cortex interaction and related methods of manufacture and use
US7212851B2 (en) 2002-10-24 2007-05-01 Brown University Research Foundation Microstructured arrays for cortex interaction and related methods of manufacture and use
WO2004043536A1 (en) 2002-11-12 2004-05-27 Neuropace, Inc. System for adaptive brain stimulation
US7565199B2 (en) 2002-12-09 2009-07-21 Advanced Neuromodulation Systems, Inc. Methods for treating and/or collecting information regarding neurological disorders, including language disorders
US20040249422A1 (en) * 2002-12-10 2004-12-09 Gliner Bradford Evan Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of movement disorders and/or other neurologic dysfunction
US7353064B2 (en) 2002-12-10 2008-04-01 Northstar Neuroscience, Inc. Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of movement disorders and/or other neurologic dysfunction
US7684866B2 (en) 2003-08-01 2010-03-23 Advanced Neuromodulation Systems, Inc. Apparatus and methods for applying neural stimulation to a patient
US20050113744A1 (en) * 2003-11-21 2005-05-26 Cyberkinetics, Inc. Agent delivery systems and related methods under control of biological electrical signals
US20070100384A1 (en) * 2003-11-24 2007-05-03 Fischell David R Implantable medical system with long range telemetry
US20050113886A1 (en) * 2003-11-24 2005-05-26 Fischell David R. Implantable medical system with long range telemetry
US7751877B2 (en) 2003-11-25 2010-07-06 Braingate Co., Llc Neural interface system with embedded id
US20050273890A1 (en) * 2003-11-25 2005-12-08 Flaherty J C Neural interface system and method for neural control of multiple devices
US20050267597A1 (en) * 2003-11-25 2005-12-01 Flaherty J Christopher Neural interface system with embedded id
US9050469B1 (en) * 2003-11-26 2015-06-09 Flint Hills Scientific, Llc Method and system for logging quantitative seizure information and assessing efficacy of therapy using cardiac signals
US11185695B1 (en) 2003-11-26 2021-11-30 Flint Hills Scientific, L.L.C. Method and system for logging quantitative seizure information and assessing efficacy of therapy using cardiac signals
US7647097B2 (en) 2003-12-29 2010-01-12 Braingate Co., Llc Transcutaneous implant
US20050203366A1 (en) * 2004-03-12 2005-09-15 Donoghue John P. Neurological event monitoring and therapy systems and related methods
US11786729B2 (en) 2004-07-15 2023-10-17 Advanced Neuromodulation Systems, Inc. Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
US7483747B2 (en) 2004-07-15 2009-01-27 Northstar Neuroscience, Inc. Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
US8606361B2 (en) 2004-07-15 2013-12-10 Advanced Neuromodulation Systems, Inc. Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
US7983762B2 (en) 2004-07-15 2011-07-19 Advanced Neuromodulation Systems, Inc. Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
US20060049957A1 (en) * 2004-08-13 2006-03-09 Surgenor Timothy R Biological interface systems with controlled device selector and related methods
US20060058627A1 (en) * 2004-08-13 2006-03-16 Flaherty J C Biological interface systems with wireless connection and related methods
US20060173259A1 (en) * 2004-10-04 2006-08-03 Flaherty J C Biological interface system
US8560041B2 (en) 2004-10-04 2013-10-15 Braingate Co., Llc Biological interface system
US8473060B2 (en) 2004-10-05 2013-06-25 The Trustees Of Dartmouth College Apparatus and method for modulating neurochemical levels in the brain
US20100305658A1 (en) * 2004-10-05 2010-12-02 Dartmouth College Apparatus and method for modulating neurochemical levels in the brain
US20060195157A1 (en) * 2004-10-05 2006-08-31 Dartmouth College Apparatus and method for modulating neurochemical levels in the brain
US20100312305A1 (en) * 2004-10-05 2010-12-09 The Trustees Of Dartmouth College Apparatus And Method For Modulating Neurochemical Levels In the Brain
US8433415B2 (en) 2004-10-05 2013-04-30 The Trustees Of Dartmouth College Apparatus and method for modulating neurochemical levels in the brain
WO2006044793A3 (en) * 2004-10-18 2007-08-23 Univ Louisiana Tech Foundation Medical devices for the detection, prevention and/or treatment of neurological disorders, and methods related thereto
US20060106430A1 (en) * 2004-11-12 2006-05-18 Brad Fowler Electrode configurations for reducing invasiveness and/or enhancing neural stimulation efficacy, and associated methods
US7437196B2 (en) 2004-11-12 2008-10-14 Northstar Neuroscience, Inc. Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects
US20060253171A1 (en) * 2004-11-12 2006-11-09 Northstar Neuroscience, Inc. Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of parkinson's disease, other movement disorders, and/or drug side effects
US7565200B2 (en) 2004-11-12 2009-07-21 Advanced Neuromodulation Systems, Inc. Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects
US20070032738A1 (en) * 2005-01-06 2007-02-08 Flaherty J C Adaptive patient training routine for biological interface system
US7901368B2 (en) 2005-01-06 2011-03-08 Braingate Co., Llc Neurally controlled patient ambulation system
US7991461B2 (en) 2005-01-06 2011-08-02 Braingate Co., Llc Patient training routine for biological interface system
US8095209B2 (en) 2005-01-06 2012-01-10 Braingate Co., Llc Biological interface system with gated control signal
US20060167564A1 (en) * 2005-01-10 2006-07-27 Flaherty J C Limb and digit movement system
US20060167371A1 (en) * 2005-01-10 2006-07-27 Flaherty J Christopher Biological interface system with patient training apparatus
US20060189899A1 (en) * 2005-01-10 2006-08-24 Flaherty J Christopher Joint movement apparatus
US8812096B2 (en) 2005-01-10 2014-08-19 Braingate Co., Llc Biological interface system with patient training apparatus
US20060189901A1 (en) * 2005-01-10 2006-08-24 Flaherty J C Biological interface system with surrogate controlled device
US7881780B2 (en) 2005-01-18 2011-02-01 Braingate Co., Llc Biological interface system with thresholded configuration
US20060195042A1 (en) * 2005-01-18 2006-08-31 Flaherty J C Biological interface system with thresholded configuration
US8060194B2 (en) 2005-01-18 2011-11-15 Braingate Co., Llc Biological interface system with automated configuration
US20060189900A1 (en) * 2005-01-18 2006-08-24 Flaherty J C Biological interface system with automated configuration
US7627383B2 (en) 2005-03-15 2009-12-01 Boston Scientific Neuromodulation Corporation Implantable stimulator
US20110077579A1 (en) * 2005-03-24 2011-03-31 Harrison William V Cochlear implant with localized fluid transport
US7801602B2 (en) 2005-04-08 2010-09-21 Boston Scientific Neuromodulation Corporation Controlling stimulation parameters of implanted tissue stimulators
US20060229688A1 (en) * 2005-04-08 2006-10-12 Mcclure Kelly H Controlling stimulation parameters of implanted tissue stimulators
US9393421B2 (en) 2005-05-26 2016-07-19 Boston Scientific Neuromodulation Corporation Controlling charge flow in the electrical stimulation of tissue
US11179568B2 (en) 2005-05-26 2021-11-23 Boston Scientific Neuromodufation Corporation Controlling charge flow in the electrical stimulation of tissue
US10065039B2 (en) 2005-05-26 2018-09-04 Boston Scientific Neuromodulation Corporation Controlling charge flow in the electrical stimulation of tissue
US20100280575A1 (en) * 2005-05-26 2010-11-04 Boston Scientific Neuromodulation Corporation Controlling charge flow in the electrical stimulation of tissue
US7801600B1 (en) 2005-05-26 2010-09-21 Boston Scientific Neuromodulation Corporation Controlling charge flow in the electrical stimulation of tissue
US8929991B2 (en) 2005-10-19 2015-01-06 Advanced Neuromodulation Systems, Inc. Methods for establishing parameters for neural stimulation, including via performance of working memory tasks, and associated kits
US20070106143A1 (en) * 2005-11-08 2007-05-10 Flaherty J C Electrode arrays and related methods
US7729758B2 (en) 2005-11-30 2010-06-01 Boston Scientific Neuromodulation Corporation Magnetically coupled microstimulators
US20100023021A1 (en) * 2005-12-27 2010-01-28 Flaherty J Christopher Biological Interface and Insertion
US9592004B2 (en) 2005-12-28 2017-03-14 Cyberonics, Inc. Methods and systems for managing epilepsy and other neurological disorders
US8868172B2 (en) 2005-12-28 2014-10-21 Cyberonics, Inc. Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
US9044188B2 (en) 2005-12-28 2015-06-02 Cyberonics, Inc. Methods and systems for managing epilepsy and other neurological disorders
US8725243B2 (en) 2005-12-28 2014-05-13 Cyberonics, Inc. Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US20070156126A1 (en) * 2005-12-29 2007-07-05 Flaherty J C Medical device insertion system and related methods
US20070225765A1 (en) * 2006-03-22 2007-09-27 Medtronic, Inc. Technique for adjusting the locus of excitation of electrically excitable tissue with paired pulses
US7689289B2 (en) 2006-03-22 2010-03-30 Medtronic, Inc. Technique for adjusting the locus of excitation of electrically excitable tissue with paired pulses
US8326431B2 (en) 2006-04-28 2012-12-04 Medtronic, Inc. Implantable medical device for the concurrent treatment of a plurality of neurological disorders and method therefore
US20070255323A1 (en) * 2006-04-28 2007-11-01 Medtronic, Inc. Implantable medical device for the concurrent treatment of a plurality of neurological disorders and method therefore
US8298176B2 (en) 2006-06-09 2012-10-30 Neurosystec Corporation Flow-induced delivery from a drug mass
US20070287984A1 (en) * 2006-06-09 2007-12-13 Neurosystec Corporation Flow-Induced Delivery from a Drug Mass
US7803148B2 (en) 2006-06-09 2010-09-28 Neurosystec Corporation Flow-induced delivery from a drug mass
US20110071493A1 (en) * 2006-06-09 2011-03-24 Neurosystec Corporation Flow-Induced Delivery from a Drug Mass
US9480845B2 (en) 2006-06-23 2016-11-01 Cyberonics, Inc. Nerve stimulation device with a wearable loop antenna
US7676263B2 (en) 2006-06-23 2010-03-09 Neurovista Corporation Minimally invasive system for selecting patient-specific therapy parameters
US20080152694A1 (en) * 2006-07-20 2008-06-26 Neurosystec Corporation Devices, Systems and Methods for Ophthalmic Drug Delivery
US20080065002A1 (en) * 2006-09-07 2008-03-13 Neurosystec Corporation Catheter for Localized Drug Delivery and/or Electrical Stimulation
US8295934B2 (en) 2006-11-14 2012-10-23 Neurovista Corporation Systems and methods of reducing artifact in neurological stimulation systems
US8855775B2 (en) 2006-11-14 2014-10-07 Cyberonics, Inc. Systems and methods of reducing artifact in neurological stimulation systems
US20110213222A1 (en) * 2007-01-25 2011-09-01 Leyde Kent W Communication Error Alerting in an Epilepsy Monitoring System
US9898656B2 (en) 2007-01-25 2018-02-20 Cyberonics, Inc. Systems and methods for identifying a contra-ictal condition in a subject
US9622675B2 (en) 2007-01-25 2017-04-18 Cyberonics, Inc. Communication error alerting in an epilepsy monitoring system
US8543199B2 (en) 2007-03-21 2013-09-24 Cyberonics, Inc. Implantable systems and methods for identifying a contra-ictal condition in a subject
US9445730B2 (en) 2007-03-21 2016-09-20 Cyberonics, Inc. Implantable systems and methods for identifying a contra-ictal condition in a subject
US8036736B2 (en) 2007-03-21 2011-10-11 Neuro Vista Corporation Implantable systems and methods for identifying a contra-ictal condition in a subject
US8560075B2 (en) 2007-04-13 2013-10-15 Alejandro Covalin Apparatus and method for the treatment of headache
US20100030299A1 (en) * 2007-04-13 2010-02-04 Alejandro Covalin Apparatus and method for the treatment of headache
US9788744B2 (en) 2007-07-27 2017-10-17 Cyberonics, Inc. Systems for monitoring brain activity and patient advisory device
US7877136B1 (en) 2007-09-28 2011-01-25 Boston Scientific Neuromodulation Corporation Enhancement of neural signal transmission through damaged neural tissue via hyperpolarizing electrical stimulation current
US10888701B2 (en) 2007-11-14 2021-01-12 Pacesetter, Inc. Implantable cardiac stimulation device and method that stabilizes ventricular rate during episodes of atrial fibrillation
US9259591B2 (en) 2007-12-28 2016-02-16 Cyberonics, Inc. Housing for an implantable medical device
US11406317B2 (en) 2007-12-28 2022-08-09 Livanova Usa, Inc. Method for detecting neurological and clinical manifestations of a seizure
US8849390B2 (en) 2008-12-29 2014-09-30 Cyberonics, Inc. Processing for multi-channel signals
US8588933B2 (en) 2009-01-09 2013-11-19 Cyberonics, Inc. Medical lead termination sleeve for implantable medical devices
US9289595B2 (en) 2009-01-09 2016-03-22 Cyberonics, Inc. Medical lead termination sleeve for implantable medical devices
US8786624B2 (en) 2009-06-02 2014-07-22 Cyberonics, Inc. Processing for multi-channel signals
US9643019B2 (en) 2010-02-12 2017-05-09 Cyberonics, Inc. Neurological monitoring and alerts
US10076663B2 (en) 2010-11-11 2018-09-18 Spr Therapeutics, Inc. Systems and methods for the treatment of pain through neural fiber stimulation
US10722715B2 (en) 2010-11-11 2020-07-28 Spr Therapeutics, Inc. Systems and methods for the treatment of pain through neural fiber stimulation
US10857361B2 (en) 2010-11-11 2020-12-08 Spr Therapeutics, Inc. Systems and methods for the treatment of pain through neural fiber stimulation
US11612746B2 (en) 2010-11-11 2023-03-28 Spr Therapeutics, Inc. Systems and methods for the treatment of pain through neural fiber stimulation
US11344726B2 (en) 2010-11-11 2022-05-31 Spr Therapeutics, Inc. Systems and methods for the treatment of pain through neural fiber stimulation
US9008780B2 (en) * 2011-10-05 2015-04-14 Case Western Reserve University Methods and associated neural prosthetic devices for bridging brain areas to improve function
US20130090706A1 (en) * 2011-10-05 2013-04-11 Randolph J. Nudo Methods and associated neural prosthetic devices for bridging brain areas to improve function
US9533150B2 (en) 2011-10-05 2017-01-03 University Of Kansas Methods and associated neural prosthetic devices for bridging brain areas to improve function
CN103932703A (en) * 2014-05-09 2014-07-23 云南大学 Method for recording sleep electrophysiological signals of primates
CN103932703B (en) * 2014-05-09 2016-06-08 云南大学 The recording method of primate sleep electricity physiological signal and device
CN105640549A (en) * 2016-03-18 2016-06-08 杭州妞诺科技有限公司 Electroencephalography epilepsy signal record analyzer and detection method thereof
US11540973B2 (en) 2016-10-21 2023-01-03 Spr Therapeutics, Llc Method and system of mechanical nerve stimulation for pain relief
US11806300B2 (en) 2016-10-21 2023-11-07 Spr Therapeutics, Inc. Method and system of mechanical nerve stimulation for pain relief

Similar Documents

Publication Publication Date Title
US3850161A (en) Method and apparatus for monitoring and counteracting excess brain electrical energy to prevent epileptic seizures and the like
US4345603A (en) Implantable battery monitoring means and method
Buettner et al. Transfer characteristics of neurons in vestibular nuclei of the alert monkey
CA1119671A (en) Method of and apparatus for automatically detecting and treating ventricular fibrillation
EP0156854B1 (en) Neurocybernetic prosthesis
US5497780A (en) Apparatus for signal analysis of the electrical potential curve of heart excitation
US3650277A (en) Apparatus for influencing the systemic blood pressure in a patient by carotid sinus nerve stimulation
US4165750A (en) Bioelectrically controlled electric stimulator of human muscles
Klinke et al. Evoked responses as a function of external and stored information
Smith et al. An externally powered, multichannel, implantable stimulator for versatile control of paralyzed muscle
FI73588C (en) Mutual non-interfering transcutaneous nerve stimulation and monitoring of the patient.
WALL et al. Pain, itch, and vibration
US4805636A (en) System for controlling muscle response
FR2369836A1 (en) IMPLANTABLE STIMULATOR WITH ALARM DEVICE
EP0570674A1 (en) Device for reducing power consumption in medical electrical equipment which is implantable in the human body
US3421512A (en) Implanted electrical device with biological power supply
ES8200561A1 (en) Pain blocking bandage.
DE69832022D1 (en) System for the treatment of neurological diseases
JP2008534041A (en) Neural stimulation apparatus and method
DE3481271D1 (en) PORTABLE DEVICE FOR MONITORING THE HEART ACTION.
Nashold et al. Paresthesias and EEG potentials evoked by stimulation of the dorsal funiculi in man
US5165404A (en) Biological tissue stimulation device with control means for determining stimulation sensitivity calculation timing
US4453547A (en) T-Wave inhibiting system
Razi et al. System-level modeling of a safe autonomous closed-loop epileptic seizure control implant
Del Pozo et al. Hybrid stimulator for chronic experiments